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Abstract 
Aims: This study examined treatment response and participant characteristics amongst 
substance misusing clients of a Cape Town low-cost out-patient treatment programme.   
Design: A theory-based approach to the evaluation was used and substance use outcomes of 
participants were measured over the three time periods of admission, 6- weeks post-
admission (immediately after the intervention) and 10-weeks post-admission as were 
elements of the Centre’s causal chain mechanism: Relationships between the domains of 
motivation (comprising the three sub-scales of Recognition, Taking Steps and Ambivalence), 
drug-taking confidence (self-efficacy), Alcoholics/Narcotics Anonymous affiliation and 
previous clean time against levels of substance use and severity of dependence at each time 
point were measured. 
Hypotheses: Substance use and levels of severity of dependence should decline over time. 
As Self-Efficacy, Taking Steps and NA/AA Affiliation scores increase, so substance use 
levels and levels of severity of dependence should decrease. Higher scores of Recognition 
and Ambivalence should be associated with higher levels of substance use and severity of 
dependence.  
Main Findings: Forty seven percent of participants reported abstinence of all substances at 
10-week follow-up and a further 13% abstained from all substances with the exception of 
alcohol which they had used only once or twice. Reductions in use of individual substances 
were high: 95% of participants who, on admission, reported use of methaquolone (mandrax), 
89% of heroin users, 84% of cocaine users and 73% of methamphetamine users reported 
abstinence of those drugs at 10-week follow-up. Self-Efficacy and Taking Steps scores 
significantly increased over time and were also significantly associated with reduction in 
substance use and severity of dependence. Higher Recognition scores were significantly 
associated with higher levels of substance use at admission and 10-week follow-up. There 
was an inverse association between amount of exposure to the treatment programme and 
levels of substance abuse and severity of dependence. NA/AA affiliation was low at all time 
points and did not appear to be associated with reductions in substance use.  
Conclusion: As substance use and substance dependence significantly decreased and as 
measurable elements in the chain of causal mechanisms changed over time consistent with 
programme causal theory, and as the change in those elements impacted on levels of 
substance use in a significant way, it can be tentatively suggested that there was a treatment 
programme effect. KEYWORDS: substance abuse, substance misuse, substance dependence 
treatment outcomes, self-efficacy, motivation, evaluation.  
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CHAPTER ONE 
 Introduction 
As substance abuse is a major contributor towards crime, poverty, injury, unemployment, 
chronic diseases and premature death, it constitutes both a health and socio-economic 
problem throughout South Africa (Department of Social Development, 2005). Since the 
breakdown of the apartheid system in 1994 and the concomitant relaxation of border 
management, South Africa has been targeted as a conduit country for onward transportation 
of drugs as well as a lucrative market for the sale of drug products (Myers & Parry, 2003). 
This has resulted in a marked increase in the availability and consumption of a variety of drug 
products (Department of Social Development, 2005) evidenced by the increase in use of 
heroin, cocaine and crystal methamphetamine (methamphetamine) in particular (Parry, 
Plüddemann, & Myers, 2005).  
Alcohol, too, presents as a serious problem: With an annual average alcohol 
consumption of 20 litres per drinker, South Africa ranks as one of the largest consumers of 
alcohol in the world. Estimates of the proportion of South Africans with an alcohol problem 
or of being at risk of developing such a problem are at 31.5% while binge drinkers (those 
who consume large quantities of alcohol at sporadic intervals) amount to about 7.5% of the 
population (Department of Social Development, 2005). The prevalence of alcohol abuse in 
the Western Cape, as well as in Cape Town, is abnormally high both within a South African 
and a global context (Wechsberg et al., 2008), with over one quarter of drinkers in the 
Western Cape consuming alcohol at ‘risky’ levels at weekends and half of all those dying 
non-natural deaths having blood alcohol levels of 0.05g per100ml or more (Parry, 2005). 
Alcohol’s strong association with crime and injury include that more than one third of 
intimate femicide perpetrators in South Africa have an alcohol use problem (Mathews et al., 
2004). A three-metro study, including Cape Town, reported an average of 49% of family 
violence perpetrators being under the influence of alcohol at the time of offence, while 23% 
of all Cape Town arrestees interviewed in 2000 reported being under the influence of alcohol 
at the time of their offences (Parry, Plüddemann, Louw, & Leggett, 2004). Another South 
African study found that more than half of drivers injured in traffic accidents were alcohol-
positive while 54.7% of patients experiencing injury through transport, violence or 
unintentional means, tested positive for alcohol (Marais, Sukhai, & Donson, 2004).  
Alcohol use immediately before sex is considered a significant predictor of 
unprotected sex, while problem drinking and soft-drug use increase the odds of drinking 
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immediately before sex and subsequent unprotected sex (Wong et al., 2007). Not only is 
substance abuse more likely to lead to high risk sexual behaviour and the concomitant spread 
of sexually transmitted diseases, but, due to its detrimental impact on the immune system, use 
of alcohol alone may speed up the progression of existing Human Immunodeficiency Virus 
(HIV) infections (Morojele et al., 2010).  
The three-metro study of crime and drugs in South Africa found that in 2000, 45.3% 
of all arrestees tested positive for at least one of six drugs including cannabis, methaqualone 
(mandrax), opiates, cocaine, amphetamines and benzodiazepines. Cannabis and mandrax use 
in particular were earmarked as drugs linked to offences with 50.2% of arrestees in 2000 
reporting lifetime cannabis use and 31.7% lifetime mandrax use (Parry et al., 2004). The 
frequency of use of these drugs in arrestees echoes findings of a comprehensive study 
addressing the prevalence and correlates of substance use among primary care clinic patients 
in Cape Town. This study offers some insight into patterns of substance use outside the 
context of admission trends: Prevalence rates of hazardous alcohol use were highest in all age 
groups while hazardous use of alcohol and other drugs combined ranked second. Cannabis 
was reported as the most used drug (apart from alcohol) at hazardous levels across all groups 
(Ward et al., 2008). These patterns of use highlight a possible disconnect between actual 
drugs used in the community and primary drug choices currently reported at Cape Town 
substance use treatment centres on admission: Currently, methamphetamine is reported in the 
highest proportions (Dada et al., 2011). However, because Ward and colleagues’(2008) and 
Parry and colleagues’ (2004) studies utilized data collected from a period prior to the recent 
spike in methamphetamine-use reports on admission to treatment, it is entirely possible that 
actual methamphetamine use in communities is now higher than reported in those studies. 
Drug abuse in the Western Cape, as well as in Cape Town, is also high in relation to 
South African and global substance abuse contexts (Wechsberg et al., 2008).  
Methamphetamine has dominated reported primary substance of abuse statistics in Western 
Cape treatment centres from 2006 (Plüddemann et al., 2009). Again, in 2011, 
methamphetamine was reported by the highest proportion of patients (37%) at treatment 
intake as the most abused drug overall. Second was alcohol at 26%, while cannabis was the 
third most popular drug of abuse at 16.5% (see Table 1; Dada et al., 2011). 
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Table 1 
Primary Substance of Abuse Reported at Western Cape Treatment Centres (Dada et al., 
2011) 
 
 
     
 
From January to June 2011  % From July to December 2011 % 
 
Alcohol  28 Alcohol  24  
Mandrax  3 Mandrax  2  
Cannabis  18 Cannabis  15  
Crack/Cocaine  2 Crack/Cocaine  2  
Heroin  13 Heroin  17  
Methamphetamine  35 Methamphetamine  39 
 
 
It is quite clear that methamphetamine use, in Cape Town in particular, presents as a 
considerable problem on a number of levels: It is considered to play a role in acts of violence 
(Plüddemann, Myers, & Parry, 2008) and recent methamphetamine use is significantly 
associated with depression and aggressive behaviour in a Cape Town high-school population 
(Plüddemann, Flisher, McKetin, Parry, & Lombard, 2010).  Its strong association with high 
risk sexual behaviour and concomitant increased risk for HIV infection (Plüddemann, Flisher, 
Mathews, Carney, & Lombard, 2008)  is of particular concern in the light of the estimated 5.6 
million HIV positive people living in South Africa in 2009, the largest HIV positive 
population in any country in the world at that time (UNAIDS, 2010).  
The prevailing high drug and alcohol usage in South Africa, the Western Cape and 
Cape Town in particular, indicates a need for effective substance abuse treatment centres to 
service multicultural communities. A number of South African research studies have to date 
been completed on treatment centre admission trends and the South African Community 
Epidemiology Network on Drug Use (SACENDU) monitors substance abuse treatment 
admissions in South Africa (Plüddemann et al., 2008, Plüddemann et al., 2009, Dada et al., 
2011). Although SACENDU provides comprehensive admission statistics of substances used 
as well as demographic trends, outcomes-based research on out-patient substance abuse 
treatment facilities in South Africa could not be identified in the literature. This apparent 
scarcity is consistent with findings of a study investigating the extent to which South African 
service providers in the substance abuse treatment field evaluate and monitor their treatment 
programmes: Routine evaluation and monitoring throughout South Africa was found to be 
relatively low, with less than half of facilities in Cape Town having ever conducted outcomes 
evaluations on their programmes (Myers, Burnhams, & Fakier, 2010).  
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An imperative, therefore, is to conduct outcomes evaluations of existing treatment 
centres to which end permission was sought and granted, after a meeting with the Cape Town 
Drug Counselling Centre’s clinical manager and senior counsellor, to conduct outcomes-
based evaluative research at this Centre. 
Research Rationale 
Rossi, Lipsey and Freeman (2004) describe the role of evaluation and outcomes monitoring 
of programmes as “to systematically investigate the effectiveness of social intervention 
programs…[and should be]…designed to inform social action in ways that improve social 
conditions” (p. 28).  
Contemporary concerns relating to the allocation of scarce resources require 
evaluations to establish the effectiveness of interventions in social contexts (Rossi e al., 
2004). Harker et al. (2008) reflect that much-needed research into interventions to reduce 
substance related harms should focus on establishing “the cost-effectiveness, efficiency and 
effectiveness of current prevention and treatment services in the [Western] province” (p. 5). 
Cost concerns are of particular relevance in the light of the limited funding available to 
substance abuse treatment centres in Cape Town (Myers & Parry, 2003), the severe 
budgetary constraints of the Cape Town Drug Counselling Centre, as well as the financial 
concerns of potential treatment seekers, reported as barriers to treatment (Myers, Louw, & 
Pasche, 2011).  
Pertinent to these financial concerns, The Cape Town Drug Counselling Centre 
employs the counselling style of motivational interviewing (MI) which is considered a 
cheaper option than other strong competing therapies due to its relative brevity (Lundahl & 
Burke, 2009). Supporting this view is that MI’s brevity of treatment and attendant cost-
effectiveness is responsible for some United States third party payers promoting MI strategies 
(Van Wormer, 2007). These findings, combined with MI’s enduring effects at 2-years post 
treatment and possibly beyond (Lundahl et al., 2010) or at least up to one year after treatment 
(Burke et al. 2003; Lundahl & Burke 2009), offer excellent financial reasons to establish 
outcome efficacy of an MI centred programme in a South African substance abuse setting.  
Good reasons for initiating a programme evaluation, cited by Rossi et al. (2004), 
include obtaining information about programme effects, using results to support programme 
advocacy or funding, and to improve on an existing programme. All of these reasons were 
valid cause for this study as an evaluation of the treatment programme in place at the Cape 
Town Drug Counselling Centre may highlight those components of the programme 
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associated with its success, initiate suggestions for possible programme improvements, and 
provide information pertinent to potential or existing funders.  
Louw (2000) describes a programme evaluation as the methodical assessment of 
programme results and the equally methodical assessment of the extent to which the 
programme itself is responsible for those findings. Standardized, objective measurements in 
outcome monitoring are limited in South African substance abuse treatment settings, with 
clinicians’ unstandardized and subjective case notes generally the means used to assess 
clients’ progress (Myers et al., 2010). Therefore, a theory and outcomes based study using 
standardized instruments may contribute towards filling a gap in the South African substance 
abuse treatment literature.  
As there was an awareness from inception of this project that a randomized field 
experiment design was impossible due to no wait-list or other potential control group, an 
alternative approach to attempt to establish whether it was only the programme potentially 
causing change, was to assess the theoretical basis of the programme and ascertain whether 
changes occurred as predicted by theory. In addition, as Rogers (2007) advises combining 
programme theory evaluation with other methods to improve causal attribution, substance use 
and substance dependence outcomes were measured. Theory-driven evaluations are based on 
the premise that programme theory is explicated by detailing expected relationships between 
“inputs, mediating processes and short and long-term outcomes” (p. 501); that constructs 
explicated in this causal chain are measured; and that results of data analyses to determine the 
extent to which the postulated relationships actually occur are analysed (Shadish , Cook, & 
Campbell, 2002).  
A previous evaluation, conducted on this Centre in 2001, focused on the relationship 
between abstinence and employment rates, as well as between abstinence and levels of 
criminality. In contrast, this study focuses on levels of use of mind-altering substances, and 
various psychological factors associated with reductions in severity of dependence and 
substance use. Only the adult treatment programme is evaluated. 
Chapter Two offers relevant background information of the Centre together with a 
description of the adult treatment programme and explains the programme theory of the 
Centre. Chapter Three includes a review of the social science literature pertaining to the 
Centre’s programme theory as well as specific aims and hypotheses. Chapter Four covers 
methods used while Chapter Five reports results. The study ends with a discussion and 
recommendations in Chapter Six.   
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CHAPTER TWO  
Cape Town Drug Counselling Centre  
Background 
This Centre is situated in Observatory, a suburb of Cape Town. It is a community-based 
organization that provides financially accessible, intensive and comprehensive treatment, 
particularly for clients from disadvantaged, lower income and under-resourced areas in Cape 
Town and surrounds. A variety of services are offered, broadly including an out-patient 
treatment programme, a youth outreach programme, a training programme, a family 
workshop programme, referrals to in-patient treatment facilities and alternative treatment 
therapies, with a view to achieving and maintaining abstinence in clients through a series of 
processes (see Figure 1). 
Interviews with the clinical manager and the Centre’s trainer and reference to the 
Cape Town Drug Counselling Centre’s Annual Report (2010) elicited the following 
information: By the early 1980’s an increasingly high prevalence of illicit drug abuse in the 
Western Cape was cause for considerable concern. Western Cape hospitals found themselves 
ill-equipped, with neither the resources nor the expertise available to adequately assist large 
numbers of patients presenting with symptoms of addiction. This situation instigated the 
formation of a Drug Action Committee by Adele Searl, a concerned parent, and Dr 
Rabinowitz, the psychiatrist in charge of out-patients at Groote Schuur Hospital, to explore 
alternative treatment options. Evidence of the degree to which this substance abuse problem 
had become a matter of concern was the representation on the committee of the Red Cross 
Society of South Africa, Groote Schuur Hospital and the Department of Social Development. 
The aim of the Drug Action Committee was to provide a service including assessment, 
treatment of suitable cases, supportive counselling and education relating to drug abuse to 
those suffering the effects of drug abuse in the greater Cape Town community.  
Through the efforts of this committee, the Centre was opened in Observatory in 1985. 
The choice of location was motivated by its close proximity to Groote Schuur Hospital and 
expected future cooperation in terms of referrals and treatment. Although initially privately 
funded, by 1986 it was receiving partial subsidization from government. The Centre opened 
with two professional staff and initially offered only individual, family and group 
counselling. 
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Figure 1: Logic Model of Drug Counselling Centre  
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In 1993, after investigation of its merits, the Centre adopted the counselling style of 
motivational interviewing. By that year a small training department had emerged in response 
to community demand for substance abuse prevention-related skills. This is now run by a 
full-time training coordinator. During the same period, acupuncture was offered as a 
voluntary alternative therapy in the out-patient programme, with aromatherapy and art 
therapy incorporated on the same basis in the late 1990’s. The youth prevention programme 
was also introduced at around this time. Nine years ago a psycho-educational element was 
incorporated into the treatment programme. 
By 1996, increased demand for services resulted in the Centre moving to larger 
premises in Observatory. Ten years later, with the help of government funding, another 
service site opened in Mitchell’s Plain. This was motivated by Mitchell’s Plain being the area 
most highly represented by clients at the Observatory branch at that time and the difficulties 
inherent in accessing the Observatory-based Centre, which is a considerable distance from 
Mitchell’s Plain and not easily accessible by public transport.  
Mission Statement 
The mission statement of the Centre is as follows: 
Our mission is to provide effective, accessible and innovative treatment, 
prevention and training services that enable South Africans to respond 
appropriately to the challenges of substance abuse. As a non-profit organization 
in the Western Cape, we aim to lead by promoting an awareness and 
understanding of substance abuse as an issue that affects us all (Cape Town 
Drug Counselling Centre, 2010). 
Goals and Objectives 
Goals and objectives of the Centre include 
 to assist people to make informed choices and to take appropriate responsibility 
regarding the use of mood altering substances, 
 to provide an environment conducive to healing, 
 to reduce the harm caused by mood altering substances and limit the increase of 
substance abuse and behaviour, 
 to provide accessible and affordable treatment, particularly to lower income groups, 
 to be accountable to clients, 
 to recruit and develop high calibre staff, 
 to be flexible with regard to challenges and demands, 
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 to approach treatment, prevention and training innovatively, 
 to evaluate the success of these approaches through research and 
 to maintain economic and financial self-sustainability. 
A desired outcome of the Centre is for clients to achieve and maintain abstinence as soon as 
possible after admission into the treatment programme. 
Target Population 
The target population of the Centre’s treatment programme is any South African challenged 
by substance abuse with a particular emphasis on attracting those from lower income groups. 
This is especially in the light of the high prevalence of methamphetamine abuse and the 
increasing use of heroin in poorer communities. Affordability and accessibility are considered 
barriers to treatment in lower socio-economic groups (Myers & Parry, 2005) therefore 
payment for treatment services at the Observatory location is calculated on a family income-
linked sliding scale in an attempt to overcome possible financial obstacles to treatment 
access.  
 Statistics from the Centre from 2011 ( Cape Town Drug Counselling Centre, 2012) 
indicate that the highest proportion of clients emanate from historically under-resourced, 
lower-income and disadvantaged communities. Target population groups are reached at high 
levels: In order of frequency, the areas most highly represented are: Athlone, Manenberg, 
Hanover Park, Woodstock, Cape Town, Observatory, Salt River and Mitchell’s Plain. 
Demand from the Mitchell’s Plain area resulted in the service site at that location opening in 
2006. The aim was to improve accessibility to a highly represented population in need. 
Currently all treatment is offered free of charge from that site.  
Clients access the Treatment Centre through a variety of ways which include: 
Referrals from health professionals in private and public settings, recommendations by social 
workers, response to outreach programmes, referrals from employers, response to Centre 
marketing tools such as pamphlets, referrals through the legal system and word of mouth 
recommendations. 
Organizational Structure 
An executive committee comprising of five members appoints a director and clinical 
manager. The entire staff at the Centre apart from the financial administrator, the training 
coordinator and a cleaner/telephonist who are directly answerable to the director, report to the 
clinical manager who in turn reports to the director. Permanent staff include two senior social 
workers, three registered counsellors, intern counsellors and a receptionist. Sessional staff 
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consists of a medical doctor, an acupuncturist, an aroma-therapist, an art therapist and two 
psychiatric registrars. 
Staff. 
Eight of the eleven permanent staff at the Centre are professionally qualified. These include 
the director, the clinical manager, five counselling staff and the training coordinator. Non-
professional staff consist of a receptionist, a general worker and a financial administrator. All 
counsellors are in possession of either a social work or a psychology degree and must be 
registered with either the Health Professionals Council of South Africa as Registered 
Counsellors or with the South African Council of Social Service Professionals as Social 
Workers. Sessional staff comprise of a doctor and a psychiatric registrar who respectively 
consult for two 1-hour and two 2-hour sessions per week. In addition the acupuncturist gives 
two 45 minute 3- hour sessions weekly and the aroma-therapist three 45 minute 3-hour 
sessions weekly. The art therapist runs a one-and-a-half-hour art therapy session with a 
maximum of 15 clients participating per session. 
Staff training. 
New counsellors undergo a two week in-house training course prior to being allocated to 
clients of their own. This comprises comprehensive training on motivational interviewing as 
based on Miller and Rollnick’s 1991 publication, Motivational Interviewing: Preparing 
People to Change Addictive Behaviour, viewing of training videos and observation of group 
sessions and assessments run by experienced staff. Trainees do not sit in on individual 
counselling sessions. New counsellors observe for four weeks before first co-facilitating 
groups and then facilitating groups alone. For at least the first month experienced staff sit in 
with new counsellors during intakes. During the training period new counsellors receive 
intensive feedback on their performance. During supervision sessions supervisors check 
whether supervisees are adhering to motivational interviewing principles as well as sit in on 
sessions at random times for the same reason. During some clinical meetings the importance 
of adhering to motivational interviewing principles is reviewed and underscored to guard 
against delivery drift.  
Centre staff frequently review programme material. Staff members share successful 
working methods with the clinical team who may elect to follow suit. Staff training is on-
going for both new and experienced staff. Staff attend outside courses and workshops and 
internal staff training opportunities are identified. 
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Staff development. 
A weekly clinical meeting is held to discuss relevant Centre issues during which one hour is 
allocated to knowledge building. Guest speakers are invited to address staff. Doctors, other 
addiction agency staff and the Centre’s own staff members may present talks related to the 
field of addiction. The clinical team performs a self-evaluative SWOT (Strengths, 
Weaknesses, Opportunities and Threats) analysis every six months with management follow-
up. A general staff meeting is held every week which all staff members attend and discuss 
Centre-relevant topics of a general nature, unrelated to clinical issues. Staff also sit in on 
colleagues’ assessments to observe and learn from each other’s individual style. 
Each clinical staff member meets weekly with an allocated supervisor, where 
supervisees may seek advice on both personal and professional issues. These sessions are 
considered important to prevent burn-out. In this regard an unfilled aromatherapy slot may be 
offered for the benefit of staff members.  
Funding 
Major current funders include government (Department of Social Development) who 
contribute approximately 50% of the Centre’s annual running costs and the Lotto that 
contributes between 15% and 20% of running costs per annum. The difference is made up by 
donations from individuals, corporations, foundations and other health services. Other 
programme resources include DVDs, educational materials and appropriately qualified staff. 
Stakeholders in the Evaluation 
Increasing the possibility of findings being used for “learning, decision-making, and taking 
action” (p.6) is a primary focus of evaluation planning, and obtaining stakeholders insights, 
perspectives and experiences are an essential part of establishing and directing that focus 
(Preskill & Jones, 2009). The expertise and knowledge of the evaluation sponsor, the clinical 
manager of the programme, in the general arena of substance abuse and relevant treatment 
protocols was particularly valuable. So too was her strong position of influence both in 
relation to the Executive Committee as well as to programme staff (both also stakeholders), 
particularly in respect of possible lobbying for improvements to the programme depending on 
evaluation findings.  
The diverse perspectives of the programme staff, all considered stakeholders, were 
also highly valued and regularly sought, both on possible evaluation questions and on an on-
going basis throughout the process. This collaboration was important to ensure smooth access 
of accurate information and to encourage maximum utility of evaluation findings. 
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Members of the executive committee were identified as stakeholders due to their 
position as policy-makers and their accountability to the community and funders. Funders are 
stakeholders in this programme too as outcomes may determine future funding strategies. 
Everyone involved in the programme would be affected by the outcomes of this evaluation in 
some way.  The Centre’s administrative staff were identified as stakeholders, not only as they 
were in a position to smooth access to files and information, but because results of the 
evaluation may impact on funding and commensurate salary adjustments.  
 Regular meetings with staff took place to derive theory rationale and to obtain 
feedback and consensus of opinion regarding the accuracy of the description of the Centre’s 
programme and causal theory as well as to discuss measuring instruments and offer interim 
feedback.   
Overview of Other Services Offered by the Cape Town Drug Counselling Centre 
Only the adult out-patient treatment programme was under evaluation, which is dealt with 
separately in Chapter 3, but below are brief descriptions of services offered apart from the 
adult treatment programme under review. 
Adolescent treatment programme 
The adolescent treatment programme, offered to school-going clients, is run along similar 
lines to that of the adult programme. It is compulsory to attend group therapy sessions, mini-
lectures, individual counselling and art therapy sessions. 
Youth outreach programme 
Prevention programmes are run in schools and tertiary institutions and mainly focus on 13 to 
18 year olds across urban and rural communities. Primary prevention programmes include 
on-going training and support for parents, teachers and schools while secondary prevention is 
in the form of intervention workshops for adolescents experimenting with mood-altering 
substances. At-risk adolescents are encouraged to seek help through the tertiary prevention 
method of the Centre’s treatment programme. 
Training programme 
The Centre offers accredited training to psychologists and social workers for Continuous 
Professional Development points. A number of different courses targeting parents, youth 
workers, community workers, students, and health-care practitioners are designed to equip 
participants with the knowledge and skills required to impact appropriately on issues of 
substance abuse in their respective environments. 
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Adult Out-Patient Treatment Programme Description 
Meetings with the designated trainer of the Centre took place to obtain appropriate 
programme information. A report based on this discussion was submitted to the clinical 
manager for comment then discussed with staff at a clinical meeting.  
Compulsory Programme Components 
The components described below take place over a six week period with clients attending six 
lectures, six individual sessions and six group sessions. 
Assessment. 
Clients first make an appointment to attend an assessment clinic held every Tuesday and 
Thursday morning. Pregnant women enjoy priority service at intake - i.e., pregnant women 
are accommodated at the following intake regardless of current bookings. Women clients are 
referred to a female therapist unless a male therapist is specifically requested. Changing to a 
female therapist is permitted at any stage.  
Clients are asked to bring with them a non-using family member or loved one and 
both complete different questionnaires relating to the client’s history and substance-using 
behaviour. Both watch the same orientation DVD about the Centre’s programme. A 
counsellor assesses written responses to questions relating to the client’s past and present 
drug use, family history and relationships, legal or criminal history and mental status. Clients 
are asked to rate their perception of their own readiness to change their substance abusing 
behaviour on a scale of 1 to 10 to offer some indication of current motivational levels for 
treatment. The counsellor spends 45 minutes with the client unless the client has used after 
midnight that morning. If that is so, the interview time is reduced to 20 minutes due to 
presumed diminished concentration levels. All of the assessment instruments were developed 
by the Centre and none is standardized. 
At the time of the assessment the counsellor recommends either an in-patient or out-
patient treatment programme. Recommendations may also be made for in-treatment at any 
time during the period of a client’s programme. Reasons may include the use of heroin 
(statistics show that these clients do better on an in-patient basis), no home support or lack of 
expected progress in the out-patient programme. For withdrawal medication or evaluation of 
more serious psychiatric symptoms, medical and/or psychiatric consultations are available. 
Once accepted into the programme clients are asked to commit to completing the 
programme by attending all sessions. This includes attending one 45-minute individual 
counselling session per week (excluding the assessment session), one 90-minute group 
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session a week, one 90-minute presentation comprising a lecture and discussion per week and 
at least two family sessions during the programme duration. Family members are asked to 
commit to attending the family workshop and family sessions.  
Individual  counselling. 
Motivational interviewing is a core component of the adult treatment programme and based 
on Miller and Rollnick’s 1991 publication, Motivational Interviewing: Preparing People to 
Change Addictive Behaviour. It is a counselling style developed on the premise that the way 
clients are spoken to regarding their substance use problems impacts on substance use levels 
(Rollnick, 2001). MI is described as “both a treatment philosophy and a set of methods 
employed to help people increase motivation by exploring and resolving ambivalence about 
behavioral change” (Lundahl & Burke, 2009, p. 1232).  
Clients are encouraged to understand that ambivalence around stopping substance use 
is normal. By developing and amplifying discrepancy in empathic ways clients are assisted to 
explore and resolve their own ambivalence in relation to their substance abusing behaviour. 
Clients are guided in evaluating their own drinking or drugging associated risks rather than 
being educated or confronted by their counsellor in an authoritarian manner. Counsellors 
adapt their approach depending on the stage of readiness to change of their clients.   
Clients receive feedback data from a drink or drugs severity questionnaire developed 
by the Centre and are assisted to evaluate their own levels of substance use in comparison 
with societal norms. To clarify terminology used in this study, this feedback process with 
pure MI may also be termed motivational enhancement therapy (MET) (Burke et al., 2003; 
Cloud et al., 2006; Hettema, Steele, & Miller, 2005). Apart from using the MET counselling 
method as the core treatment tool, the Centre also uses referral to Alcoholics Anonymous or 
Narcotic Anonymous groups, drug testing, group therapy, psycho-educational lectures, 
family counselling sessions, and family workshops as additional treatment resources. 
Alcoholics Anonymous and Narcotics Anonymous affiliation. 
Throughout the programme duration clients are strongly recommended to attend Narcotics 
Anonymous (NA) or Alcoholics Anonymous (AA) meetings regularly. Counsellors verbally 
establish attendance consistency. All clients leave their first session with an AA or NA 
meeting schedule. 
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Drug testing. 
Heroin users must test negative before beginning therapy. At the first session the counsellor 
may sell the client several test kits and retain them for use by the client as required. Drug 
tests are administered on a random basis during the client’s treatment. 
Group therapy. 
In accordance with the MI counselling style, counsellors look for opportunities to affirm 
helpful behaviour as well as highlight, explore and amplify damage caused by clients’ drug 
use. Groups are often run on a co-therapy basis to allow for counsellors to talk to each other 
in order to steer groups in desired directions. A member of NA addresses the groups once 
every month. Men’s and women’s groups are run separately with the exclusively women’s 
group including only women clients and only women counsellors as facilitators. 
Psycho-educational lectures and discussion groups. 
Once a week clients must attend a session in the interactive format of a lecture interspersed 
with discussion. Each lecture is prefaced by acknowledging the benefit of relevant knowledge 
in aiding recovery. After each session clients receive a worksheet related to the topic and 
specific areas covered which they complete in time for discussion at their next individual 
counselling session. Topics include: 
 Understanding Addiction, which deals with the concept of addiction as a 
disease and covers aspects relating to its primary, progressive, chronic and 
potentially terminal nature. Characteristics of addiction are discussed, namely: 
ambivalence, tolerance, shame, loss of control, preoccupation with drugs, 
continued use despite damages, lying and manipulation,  
 Denial, which focuses on this and other defence mechanisms including 
bargaining, minimization, intellectualization and blaming. The concept of a 
sense of entitlement is also covered, 
 Powerlessness, which reinforces the need for clients to acknowledge that they 
need help in overcoming their addiction and that they cannot use substances in 
a controlled manner. It is emphasized that powerlessness is not synonymous 
with weakness, 
 Personal Loss, where the emphasis is on amplifying losses experienced in the 
areas of finances, relationships/emotional, career/school/studies, self-esteem 
and spirituality and recognizing the courage and honesty required in 
acknowledging their loss. An important element is the reinforcement of the 
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need for clients to acknowledge what has not yet been lost but could be if 
drugging continues, 
 Relapse, which deals with individuals’ recognition of potential relapse triggers 
and underscores the inclusion of drugging behaviour as an indication of 
imminent relapse. Clients are encouraged to identify differences in behaviour 
between active addiction and recovery in the spheres of feelings, behaviour, 
dreams and hopes, physicality, work/studies, relationships and spirituality and 
 HIV/AIDS and addiction, where clients have an opportunity to acknowledge 
their risky sexual behaviour related to their addiction. Clients are given 
statistics relating to prevalence of HIV and AIDS. Transmission methods and 
high-risk behaviours are also discussed as well as clients’ feelings around 
those issues. The issue of shame is covered as a related theme. 
Family counselling sessions. 
Affected family members join clients and their counsellors for a facilitated discussion of 
family related issues, with the focus on clients’ behaviour. At least two family sessions which 
range in time from 45 minutes to two hours must be attended during the treatment period. 
These are in addition to individual counselling sessions. Family sessions are often run on a 
co-therapy basis if families are large or considered challenging to engage. Cultural 
differences between counsellors and clients may be addressed by including a second 
counsellor of a similar cultural background to the family in the session. 
Family workshops. 
It is compulsory for families of clients to attend at least one of the monthly family 
workshops.  Families are educated about addiction and the effects and they are offered the 
opportunity to share their experiences. Participants must be clear of substance abuse 
themselves for at least two years to qualify for participation. Family members are advised to 
join Nar-Anon or Al-Anon. Nar-Anon is an organization affiliated with NA but for the 
benefit of family and friends of substance abusers. Al-Anon operates identically in relation to 
AA but is orientated around families of alcoholics. At every family workshop half an hour is 
allocated for a Nar-Anon member to address the group about benefits associated with the 
organizations.  
Optional additional services. 
A number of voluntary additional services are offered: 
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Referrals. 
At assessment or at any stage, with clients’ consent, clients may be referred to an in-patient 
treatment centre or another facility better suited to their needs. The Centre refers clients to 
various state run institutions including De Novo in Kraaifontein, the Kensington Treatment 
Centre in Maitland and the Western Cape Youth Rehabilitation Centre in Eerste River 
(adolescents only). Requirements for admission to these institutions include a referral from a 
social worker and both a medical and psychiatric evaluation. Heroin patients may be directed 
to Stikland as an in-patient to detox. Alternatively they may be advised to detox as an out-
patient on medication under medical supervision.  
Aftercare programme. 
All clients have the option to stay on in an aftercare programme after completion of the six 
week treatment programme. Attendance of an aftercare programme is contingent on clients 
attending NA or AA meetings. Although proof of this activity is through self-report, 
counsellors are confident of distinguishing attendees from those not attending meetings. The 
aftercare programme consists of a combination of group therapy sessions if requested by the 
client and individual counselling sessions, or just individual counselling sessions. Clients 
may also make use of sessional services in aftercare. The exact permutation is tailored 
towards individual needs and length of time of attendance is decided equally individually.   
HIV/AIDS service. 
HIV/AIDS information and advice is available free of charge and offered throughout the 
programme due to perceived high risk behaviour prevalent amongst substance abusers. 
Voluntary counselling and drug testing is available to all drug users regardless of whether 
they are in the Centre’s treatment programme. All counsellors are also trained as Voluntary 
Counselling and Testing counsellors so may administer pre- and post-test counselling. HIV 
testing is done at the Centre through the medical doctor. 
Medical and/or psychiatric consultations. 
Clients have access to the services of a medical doctor and psychiatrist for withdrawal 
medication and for evaluation of more serious psychiatric symptoms. 
Art therapy. 
In art therapy, the art therapist interprets and discusses clients’ paintings and underlying 
emotions in a supportive group setting. 
Aromatherapy massage. 
The aroma-therapist massages the body to encourage relaxation. 
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Acupuncture. 
Acupuncture is offered to assist in reducing withdrawal symptoms and to re-energize the 
body. 
Intake of relapsed clients. 
Relapsed clients undergo the same process as at their first admission and are re-evaluated in 
the same spheres as at the first assessment. Returning clients are allocated the same 
counsellor if possible and follow the full programme again. 
 
Programme Rationale and Causal Theory behind the Compulsory Components of the 
Adult Treatment Programme 
Although a formal needs assessment was not undertaken, this treatment programme was 
initiated as a direct response to an explicit need for treatment services in lower socio-
economic communities. This was manifested at the time by persistent presentation in medical 
settings of substance abuse in patients with little or no resources. 
Selections of interventions are based on a variety of factors: From inception of the 
programme the counselling style was client-based; the then-prevailing preferred counselling 
style in treatment settings. The shift to motivational interviewing was driven by evidence of 
this counselling style’s utility. The concept of involvement of families in substance abuse 
treatment contexts was accepted at the time of inclusion as a desirable, scientifically based 
component in substance use programmes. The psycho-educational element was introduced in 
keeping with accepted social science theory relating to the use of knowledge building as a 
tool to change attitudes and increase motivation to change substance abusing behaviour. 
Causal Theory 
Although programme theory emphasises the responses of participants to programme 
activities, Weis (1998) suggests that underpinning every social programme is a theory of 
implementation. This focuses on the delivery of programme services rather than the 
mediating processes between programme services and the achievement of programme goals. 
Programme theory and the theory of implementation evolve in an integrated way and 
combined, form a programme theory of change (Weis, 1998).  In this study, establishing the 
Centre’s programme causal theory is in compliance with the premise of theory-based 
evaluations that programme theory is explicated by detailing the expected relationships 
between elements in the causal chain mechanism before analysing their contributions to 
outcomes (Shadish et al., 2002). To this end the causal theory rationale of the Centre’s 
programme was derived from the clinical manager and counselling staff at three meetings 
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over six weeks. These meetings were an important part of the planning process to obtain 
feedback and consensus of opinion regarding the accuracy of the description of the Centre’s 
programme and causal theory which were adjusted and confirmed with programme staff to be 
representative of a combination of their underlying assumptions.  
The causal theory of the treatment programme is grounded in the assumption that 
participation of substance abusers and their families in the combination of the compulsory 
activities offered by the programme will provide the intermediate outcomes of knowledge, 
attitude and behaviour changes necessary to result in the desired longer term outcome of 
clients’ sustained abstinence from any mind-altering substances (see Figure 2).  
The interactions between the programme’s operations and the target participants are 
all considered to contribute towards improved self-efficacy and increased motivation levels 
which are characteristics theorized as associated with sustained abstinence. Attendance at NA 
or AA meetings is also expected to contribute towards continued abstinence.  
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Figure 2: Chain of causal mechanisms
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Proximal outcomes for families include support of the treatment intervention, attitude, 
knowledge and behaviour changes as well as attendance at Nar-Anon or Al-Anon meetings. It 
is proposed that the combination of these intermediate outcomes leads to improved family 
health which in turn creates an environment conducive to clients’ recovery. Detailed 
postulated interactions between target participants and the programme follow. 
Individual counselling. 
An adapted version of motivational interviewing, motivational enhancement therapy (MET), 
using the key techniques of exploring ambivalence and awareness of stage of change in 
clients is considered by Centre staff to be associated with reduced drugging or drinking.  
Counsellors tailor their approach depending on the stage of change prevalent in their 
clients. This is designed to lead to early changes in motivational levels with a view to 
increasing the probability of clients’ return to the Centre. Goals are set to elicit sufficient 
motivational levels for clients to wish to change their own substance abusing behaviour. 
Application of the MET techniques of exploring ambivalence through expressing empathy, 
developing discrepancy, avoiding arguments, rolling with resistance (working with, instead 
of confronting resistance) and supporting self-efficacy is postulated to result in healthier 
behaviours and attendant abstinence. Self-efficacy is a self-belief reflecting levels of self-
perceived judgement of one’s personal capability of behaving in a certain way in a specific 
situation (Bandura, 1977).  
Group therapy. 
The MI component in the group therapy context at the Centre is intended to support 
individual counselling methods and effects. Programme theory includes that benefits of group 
therapy include learning from peers at different stages of recovery as well as receiving group 
encouragement and feedback. Both are expected to increase levels of motivation to change 
behaviour. Observation of others’ struggles but yet continued abstinence is thought to offer 
clients’ hope and the courage to change their own behaviours and in turn considered to 
contribute towards feelings of self-efficacy. Separate-sex groups are expected to result in 
more honest sharing and a concomitant reduction of shame and stigma associated with anti-
social or self-perceived shameful behaviours.  
NA or AA attendance. 
NA or AA attendance is strongly encouraged throughout the programme and beyond as it is 
postulated that more successful outcomes are associated with more attendance at NA and AA 
meetings. In addition, having a sponsor and undertaking step work, which is working within 
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the associations’ particular framework of 12 steps to recovery, are considered to increase the 
possibility of sustained abstinence.  
Psycho-education. 
The psycho-educational component of lectures and discussions on relevant topics is 
considered to equip clients with appropriate knowledge on mind-altering substances and their 
effects together with the consequences of substance abuse. This knowledge is theorized to 
support the content of all other programme components by offering informative and objective 
insight into pertinent issues. The format of the psycho-educational discussions is designed to 
remove psychological blocks and denial issues relating to substance abuse.  
Drug tests. 
Drug testing is considered to act as a motivating factor not to use due to unpleasant 
consequences relating to positive results. It also allows counsellors to verify clients’ progress 
and direct individual counselling sessions accordingly. 
Family involvement. 
Assessment. 
The programme theory postulates that successful outcomes are associated with the level of 
healthy support for the client outside the programme and that a system supporting enabling 
behaviours towards the substance abuser feeds addiction. Enabling behaviour in this context 
is any behaviour which relieves substance abusers from the natural consequences of their 
own actions. Identifying and amplifying collateral damage is considered a motivational factor 
on the path to abstention. This is best achieved through the presence of a loved one at 
assessment. This is expected to reduce the possibility of fact-manipulation by the client as 
well as to prevent clients from minimizing damage caused by their substance abuse. This is 
thought to offer a clearer clinical picture and provides information for future use in a 
counselling context. 
Family workshops. 
The family workshop is a vehicle expected to parallel improvement of the health of families 
with that of their substance abusing family members. This is in turn expected to alter clients’ 
domestic environments in such a way as to be less conducive towards substance abuse. 
Highlighting enabling behaviour is expected to result in the formation of appropriate 
boundaries offering fewer manipulation opportunities to the substance abuser. Feelings of 
shame and guilt experienced by families of drug abusers are expected to diminish through 
exposure in a forum designed for sharing experiences and identifying with others in similar 
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situations. This is expected to contribute towards overall family health. The MI counselling 
style is consistently applied in all interactions between counselling staff and clients as well as 
their families. The expectation is that exploration and resolution of ambivalence relating to 
denial and acceptance of family members’ behaviours will increase awareness and promote 
proactive family environments. 
Family members are also exposed to a psycho-educational component on the premise 
that through this knowledge they will alter their behaviour and attitude towards the addict in 
constructive ways conducive towards abstinence. A member of Nar-Anon addresses each 
family workshop with the aim of encouraging family members to join the organization and 
introduces them to a continuous support mechanism outside the treatment environment. This 
is expected to assist in maintaining inter-personal family boundaries and perpetuating a home 
environment less conducive towards substance abuse. 
Family sessions. 
Counsellors facilitate discussion around the experience of family life with a substance abuser 
while learning more about clients’ backgrounds. This knowl dge may inform their responses 
to clients in individual counselling settings. In family sessions the family articulates more 
collateral damage of the substance abuse in the presence of clients, as it is postulated that 
these expressions of harm will further motivate clients to change their behaviours, as will 
affirming change and highlighting areas requiring change. Again MI counselling techniques 
are used to maximize the benefit of these sessions and by rolling with resistance, affirming 
self-efficacy, reflective listening and highlighting discrepancies and ambivalence in a family 
context, counsellors expect that both clients and families should improve on behaviours 
previously supporting a substance-abusing lifestyle. Both family sessions and family 
workshops are expected to result in family support of the treatment intervention style, as well 
as improved family health, and are considered contributory factors in achieving and 
maintaining abstinence.  
Conclusion 
This is a stable and mature programme with the separate programme components run 
along particular and explicit written guidelines. Programme staff clearly share an implicit 
conceptualization of the change processes initiated by the programme as well as the resultant 
desired and expected proximal, intermediate and longer term outcomes in programme 
participants. This programme theory will be tested against the prevailing social science 
literature in the following chapter. 
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CHAPTER THREE 
Approach to the Evaluation 
Review of relevant social science literature 
In keeping with Rossi and Lipsey’s (2004) directive to evaluators to conduct an independent 
analysis of the assumptions and expectations upon which programmes under evaluation are 
founded, a search on the relevant current social science literature was conducted. It was 
concluded that the Centre’s programme theory, of all compulsory components of individual 
counselling, group therapy, psycho-education, NA/AA attendance, drug testing and family 
involvement, was well-supported by prevailing social science theories. This support for each 
component of the programme is addressed below.   
Motivational interviewing. 
The programme description and causal theory of the Centre’s MET counselling component 
offers evidence of fidelity to the principles of MET for which there is considerable support in 
the literature related to its effectiveness in a substance abuse environment. As the Centre’s 
programme incorporates the add-on component of MET to standard MI both MET and MI 
literature is relevant to this study. MET is the most widely used adaptation of motivational 
interviewing in a substance abuse treatment context (Burke, Arkowitz, & Menchola, 2003; 
Holleran & Steiker, 2009). Structured feedback data are used to compare clients’ substance 
use and behavioural health with accepted norms and so increase awareness and discrepancy 
in clients (Miller & Rollnick, 1991) which is positively associated with change talk (Vader et 
al., 2010). This is expected to lead to greater feelings of self-efficacy and self-motivation to 
change behaviour (Read, Kahler, & Stevenson, 2001), and hence, to behavioural change. 
A meta-analysis of 119 empirical studies viewed MET and MI as one intervention and 
reports equal effects to strong comparison groups utilizing specific interventions, viz. 
Cognitive Behavioural Therapy (CBT) or 12-Step facilitation groups. However, in a 
moderator analysis using MET as a potential moderating variable to contrast basic MI with 
MET against weak comparison groups (treatment as usual, waitlist control or written 
materials) findings reflect that MET is significantly more likely than MI to produce positive 
change in behaviour (Lundahl, Kunz, Brownell, Tollefson, & Burke, 2010) and significantly 
more effective than MI as a stand-alone treatment (Burke et al., 2003; Lundahl & Burke, 
2009). Findings from Project MATCH indicate that MET is as successful as CBT or a 12-
Step facilitation programme when administered on an individual basis to clients without 
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psychopathology (Hettema et al., 2005): Project Match was a large statistically powerful trial 
conducted in the U.S. to establish how alcoholics with different characteristics responded to 
various types of therapeutic interventions (Del Boca & Brown, 1996). Another meta-analysis 
compares the results of 30 controlled clinical trials with meta-analytic comparative data of 
psychotherapeutic treatment in general. Findings include that the percentage of people who 
showed noticeable improvement or abstinence in drinking and drugging (51%) after MET 
interventions was significantly greater than the 37% who improved with treatment as usual 
(Burke et al. 2003).  
Rates at which people retain the effects of treatment are good: Lundahl et al. (2010) 
report that MI is durable at 2-years after treatment and possibly beyond whereas Lundahl & 
Burke (2009) conclude that outcomes may be durable for up to 1 year after treatment. The 
effects of MET do not weaken significantly over time compared with other comparison 
groups (Burke et al., 2003). In the Project MATCH study MET outperformed CBT and 12-
Step facilitation therapy on1-year and 3-year follow-ups in drinkers with high baseline anger 
(Project Match, 1997). This is particularly notable as during that study MET treatment was 
restricted to four sessions whereas the other two approaches delivered 12 sessions each 
(Project MATCH, 1997). Due to the relative brevity of MET treatment, its cost effectiveness 
is probably better than competing strong comparison treatments (Lundahl & Burke, 2009).  
Therefore, as this extensive body of evidence informs us that MET is considered at 
least as effective as CBT and 12-Step programmes, similar in terms of durability and 
considerably shorter (and therefore cheaper) than other competing therapies, the MET 
counselling style is a sensible and appropriate therapeutic choice for this Centre due to 
budgetary and time constraints. 
Group sessions. 
The Centre’s causal theory of group therapy is supported by the relevant literature: Group 
therapy provides peer support paralleling the individual counselling experience. In this 
setting, personal self-examination may be more in-depth due to emotions evoked and insight 
obtained from other group members. As members of the group are at different stages of 
recovery, new and ambivalent members are exposed to others longer in recovery and who 
endorse abstinence. This peer role-modelling provides motivation and hope to those in early 
recovery or those who are struggling to achieve or maintain healthy behaviours (Martin et al., 
2007).  
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Group work also has the advantage of preparing individuals for participation in self-
help groups, viz. NA or AA and is extremely cost-effective (Mueser & Pierce, 2007). Group 
therapy is described as a healing process through interconnectedness with others experiencing 
similar challenges. It assists in reducing levels of self-absorption and co-dependence and 
improves emotion regulation while increasing self-esteem and improving behaviours, 
especially self-care (Khantzian, Golden-Schulman, & McAuliffe, 2004). Topics of child 
abuse and domestic violence, of particular sensitivity to women, are best addressed in single 
sex groups (Lafave, Desportes and McBride, 2009). Salience of these issues in a substance 
use treatment environment is underscored by findings of a study investigating levels of abuse 
and violence in a methamphetamine treatment programme, which stated that 58% of the 
women reported a history of sexual abuse and violence (Cohen et al., 2010). 
As individual counselling is required to engage clients on a personal level, group 
therapy should not substitute individual counselling but rather augment the individual 
treatment process (Ghodse, 1995). As group therapy is offered in addition to individual 
counselling at the Centre and its delivery and aims are supported by accepted social science 
theories, it can be considered an appropriate and evidence-based component of the treatment 
programme. 
NA/AA affiliation. 
The assumptions of the Centre’s programme theory that NA/AA affiliation leads to reduced 
substance use is consistent with the literature. NA and AA-related coping skills are reported 
as predictive of reduced substance abuse, with involvement in the AA having independent 
positive effects on substance use disorders as well as with positive changes in social network 
support (Laffay, McKellar, Ilgen, & Moos, 2008). Read et al. (2001) encourage clinicians to 
refer clients to programmes such as AA as they found that 12-Step approaches are an 
effective source of help particularly in an alcohol use context. 
There is evidence of a causal connection between NA/AA affiliation and increased 
self-efficacy (Laffay, McKellar, Ilgen, & Moos, 2008) and NA/AA affiliation predicts high 
levels of self-efficacy at follow-up as well as being significantly associated with other change 
process constructs, viz. commitment to abstain, cognitive coping, behavioural coping and 
primary appraisal of harm (Morgenstern, Labouvie, McCrady, Kahler, & Frey, 1997). 
Reading 12-Step literature, providing service and being a sponsor in an AA context is 
associated with better alcohol-related outcomes (Timko, De Benedetti, & Billow, 2006).  
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NA/AA affiliation is associated with sustained motivation, predicts sustained levels of 
commitment to abstinence at follow-up and independently predicts better short-term 
outcomes (Morgenstern et al., 1997) and greater AA-related coping predicts more 
improvement in substance abuse problems at 4-years follow-up (Laffay, McKellar, Ilgen, & 
Moos, 2008). Rates of abstinence compared at 2 years follow up in participants attending 
either a cognitive behavioural programme or attending 12-Step self-help groups reflected 
substantially better abstinence rates achieved by the 12-Step group (49.5%) than that of the 
cognitive behavioural group (37.5%) (Humphreys & Moos (2007). Cook (1988) comments 
on the effectiveness of the AA in the context of the extreme attitude changes experienced by 
some patients as simulating a religious conversion. A study looking at spiritual transcendence 
as a predictor of psychosocial outcomes from a substance abuse programme found that 
involvement in a spiritually-grounded programme such as that of the AA may be predictive 
of recovery (Morgenstern et al., 1997; Piedmont, 2004). 
Psycho-education. 
The Centre’s programme theory in relation to psycho-education is also well supported by 
social science literature: Psycho-education through the use of informational materials, 
discussion and teaching is used in a structured group format to inform addicts about the 
medical, behavioural and psychological consequences of their addictions. Raising awareness 
of these consequences is intended to educate addicts and lay a foundation of knowledge 
within which contexts further intervention treatments are delivered (Khantzian et al., 2004). 
Leshner (1997) advises incorporating an HIV prevention intervention in treatment facilities  
while a study exploring links between HIV and alcohol indicates the importance of HIV 
related services: In particular, the inclusion of knowledge-building and personnel trained in 
HIV-related counselling into substance abuse treatment programmes should reduce high-risk 
behaviour (Morojele et al., 2010). 
Family involvement. 
The programme theory relating to family involvement is consistent with the literature: The 
negative impact of family members’ substance abuse has far-reaching effects on family 
systems (Velleman & Templeton, 2003). As the family is a fairly stable system, its inherent 
resistance to change makes it a necessity for family members to become involved in seeking 
their own health, which better improves the likelihood of their family members’ successful 
treatment outcomes (Ghodse, 1995). This involvement is associated with success ranging 
from persuading the abuser to enter into treatment to long term beneficial outcomes for 
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substance abusers and their families. Family involvement from the initial stages of treatment 
leads to a clearer clinical assessment of the frequency and amount of substance abuse as well 
as its impact on those around them (Steinglass & Kutch, 2004).   
Therapy should be based around the behaviour of the substance abuser and 
developing a plan to change interactional patterns of the families and substance abusers 
(Steinglass & Kutch, 2004). It enables identification of unhelpful family behaviours and their 
roles in the perpetuation of substance abuse. Understanding family members’ experiences and 
developing interventions for them may result in a beneficial impact on the abuser. Some of 
these adjustments may be achieved by teaching family members strategies to reduce 
protection of substance abusers from the consequences of their own actions, communicate 
about the topic of substance abuse, increase coping skills, and eliminate reinforcers of 
substance abusing behaviours (Copello, Velleman, & Templeton, 2005; Steinglass & Kutch, 
2004). 
Family therapy has been proven as superior to control conditions at post-treatment 
substance-use follow-up (Copello et al., 2005). Multiple-family therapy where different 
families are exposed to each other’s experiences is particularly beneficial as members may 
recognize similar negative behavioural patterns in their own families and be motivated to 
alter them accordingly (Ghodse, 1995).  
In the light of the diversity of cultures within South Africa, findings from cross-
cultural international studies have particular relevance for the Centre’s family workshop 
programme. These indicate that families from an assortment of cultural backgrounds report 
extremely similarly on their experiences of living with substance abusing family members, 
indicating shared understandings of relevant issues (Copello,et al., 2005; Velleman & 
Templeton, 2003). 
 Lack of involvement may undermine the treatment programme of the substance 
abuser, as through ignorance family members may unconsciously contribute towards 
maintenance of the substance-abusing behaviour (Ghodse, 1995). Some of these behaviours 
include protecting the addict from the consequences of substance abuse, collusion in denial of 
the substance use problem or keeping the problem a secret. However, family members who 
are able to recognize and understand the process of addiction and the importance of 
maintaining a pragmatic perspective of the problem can assist addicts considerably by 
adjusting their own behaviour to reduce accommodation of substance abuse (Martin, 
Weinberg, & Bealer, 2007).  
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With appropriate involvement, families may become resources for substance abusers 
to increase healthy changed behaviours. To this end membership of Naranon or Alanon is 
advocated, on the basis that these self-help groups give support to families of addicts by 
promoting raised self-esteem in family members and offering self-care tools with a view to 
the obtainment and maintenance of levels of emotional independence from their substance 
abusing family members (Steinglass & Kutch, 2004). 
All of these findings support the Centre’s programme theory, which is therefore 
compatible with prevailing social science theory. Programme implementation is in harmony 
with programme theory: What is delivered to clients in terms of the programme description is 
in alignment with the programme theory. Social science theory also supports the Centre’s 
choice of programme components integrated to comprise the full programme. It can therefore 
be concluded that the programme impact theory is plausible and well-founded.  
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CHAPTER FOUR 
Method 
Specific Aims and Hypotheses 
Levels of substance use and severity of dependence were assessed as indicators of outcomes 
success. Due to the lack of a control group, and in keeping with the theory-based evaluation 
approach to explicate and measure expected relationships in the causal chain (Shadish et al., 
2002), an attempt was made to investigate whether certain measurable elements in the 
Centre’s chain of causal mechanisms changed over time, consistent with programme causal 
theory and also whether the change in those elements impacted on levels of substance use in 
any significant way.  
It was decided to assess the efficacy of the adult treatment programme from three 
perspectives over the three time periods of admission, 6 weeks post-admission and 10 weeks 
post-admission. The first was to determine whether substance misuse decreased while in 
treatment. Secondly, it was decided to establish whether any changes of client functioning in 
the domains of self-efficacy and NA/AA affiliation levels, levels of substance use and 
motivational levels took place over these times. Motivational levels were divided into three 
sub-categories comprising Recognition (of the substance use problem), Taking Steps 
(towards addressing the substance use problem) and Ambivalence (towards the substance use 
problem). Expectations were that self-efficacy, NA/AA affiliation and taking steps scores 
would increase from admission to 6 weeks post-admission and be at least sustained between 6 
weeks post-admission and 10 weeks post-admission while substance use, dependence and 
ambivalence levels should decrease over the same time periods.  
The third approach was to assess the factors associated with the abstention rate and 
reduction in substance use rate of programme clients at 6 weeks post-admission and 10 weeks 
post-admission and to determine the extent to which the postulated relationships actually 
occurred. Hypotheses in this regard were formulated on the basis of prevailing social science 
theory: That NA/AA affiliation at end of treatment would be inversely associated with 
abstinence or lower levels of substance use and substance dependence at both follow-up time 
points and that self-efficacy levels at 6 weeks post-admission would be associated with 
abstinence or lower levels of substance use at 10 weeks post-admission.  
Taking steps scores at admission were expected to be predictive of abstinence or 
lower levels of substance use at both follow-up time points while recognition scores on 
admission were expected to be positively associated with higher levels of substance use at the 
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same times (Miller, & Tonigan, 1996). From a potential treatment-tool perspective, the 
Recognition sub-scale could be a useful instrument with which to determine problem 
severity. As taking steps scores are predictive of successful change, counsellors may gauge 
motivation levels of clients before and during the treatment process.  
The hypothesis was added that an inverse association of previous clean time to 
reduced substance use or abstinence after treatment exists after this was postulated by Centre 
staff during preparatory meetings. The literature makes no predictive claims relating to the 
sub-scale of Ambivalence and comments only on its efficacy at gauging those levels as a 
treatment tool. However, Centre staff expressed interest in the relationship between levels of 
ambivalence on admission and substance use outcomes, hypothesizing a positive relationship 
between the two which was why this was added to the hypotheses. 
Clinical staff were also interested in ascertaining clients’ perceptions of the treatment 
programme and their levels of satisfaction with their experience of aspects of the Centre’s 
treatment process. Perceptions of staff sensitivity, turn-around time of service-delivery and 
perception of programme efficacy were targeted for feedback. 
Design and Setting 
Rossi, Lipsey and Freeman (2004) refer to a randomized field experiment as the “gold 
standard” (p. 237) for optimal results in research designed to assess programme intervention 
effects due to its inherent control of threats to internal validity. Design options, however, 
were somewhat limited, as core characteristics of the randomized control design model 
precluded its use in this evaluation project. Initial enquiry into the possibility of utilizing a 
waiting list control group was met by the response that incorporation of that method was 
impossible due to the Centre’s treatment-on-demand facility with no waiting list component. 
Without this control or any other method of creating a control group which would not be 
considered by the Centre’s management as impinging on treatment quality, a randomized 
control design was impossible. In an attempt to ascertain whether any changes occurring in 
the areas of interest under study were due to programme effect, the alternative approach of a 
theory-driven, pre-post experiment with a second follow-up was decided upon. This was to 
allow an assessment of the theoretical basis of the programme to ascertain whether changes 
occurred as predicted by theory and whether the impact of the intervention was maintained 
over time.  
To increase the possibility of causal inference, multiple measures were obtained at 
admission, 6 weeks post-admission and 10 weeks post-admission. A major feature of the 
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randomized control trial is that history and maturation effects are controlled for, leaving room 
only for chance differences (Shadish et al., 2002). Although a randomized control experiment 
could not be conducted in this study, the possibility of maturation effects in the form of 
spontaneous remission confounding results was not a major source of concern, as 
spontaneous remission from drugs usually occurs gradually over a long time period (Price, 
Risk, & Spitznagel, 2001). Due to the out-patient nature of the programme and potential 
external factors of influence confounding treatment results, participants who received 
alternative treatment for their substance use during the ten weeks after admission were 
excluded from the study to control for history effects. There was very little risk of statistical 
regression towards the mean confounding results as participants were not selected based on 
extremely high or extremely low scores. Selection bias itself was not of concern as all clients 
agreeing to participate in this study were interviewed.   
Other threats to internal validity were contained by measuring the same respondents at 
pre- and post-treatment times. This controlled for age, gender and various life circumstances 
effects such as changes in domestic and financial situation which were not likely to change 
much over the treatment and follow-up period. The main researcher has no vested interest in 
the Cape Town Drug Counselling Centre and experimenter effects were contained by 
interviews only being administered by her throughout the period of the study, with the 
occasional assistance of one Master’s level researcher trained by her. 
 Attempts were made, therefore, to control for threats to internal validity and in 
addition to measuring participants’ responses over three time periods, the theory-based 
component of the evaluation further strengthened the possibility of increasing causal 
inference.   
The programme length is six weeks with core compulsory programme elements of 
attendance of six lectures, six individual sessions and six group sessions (18 sessions in all). 
Three weeks into the study it was clear that attendance of participants of compulsory sessions 
ranged from “no sessions attended” to “all possible sessions attended”. A meta-analysis 
studying comparative data of psychotherapeutic treatment in general, reports a significant 
positive relationship between higher treatment doses and better study outcomes (Burke et al., 
2003). In the light of these findings a dosage variable was incorporated into the design of the 
study to gauge the relationship between the number of sessions attended and substance use 
over time, and to establish whether this amount of exposure was associated with changes in 
variables of interest. This was in an attempt to assess whether it was the programme that 
made the difference (if any) in substance use and severity of dependence scores, on the basis 
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that, if the programme did make a difference, clients who received more of the programme 
should have experienced the greatest reductions in substance use and levels of severity of 
dependence.    
Statistical power. 
The number of cases necessary for credible testing of correlation was calculated as follows: N 
≥ 50 + 8m where m is the number of independent variables: Hence, 50 + (8 x 6) = 98. 
However, as these predictors were all intended to be individually tested too, a second 
formula, 98 + m + m applied. Therefore at the time of the design of this study, 110 was the 
minimum number of cases required to ensure statistical power and generous allowance was 
made for attrition or alternative treatment referrals. These calculations were in compliance 
with Tabachnik and Fidell’s (1996) directive relating to statistical testing involving multiple 
regressions. The timeframe of this study was dictated by the prerequisite of 110 participants 
derived in the planning stage through calculations assessing potential statistical power.  
Measures 
Meetings with clinical staff provided opportunities to discuss expectations around the 
research project, as well as what postulated behaviour changes within the components of the 
programme the staff themselves would consider useful to measure. Motivation levels, self-
efficacy, affiliation with Alcoholics or Narcotics Anonymous and levels of drinking or 
substance use were agreed upon as domains of interest. The results of research of possible 
measurement tools both relevant to the aspects of the programme identified as indicators of 
success, and of appropriate length to comply with an agreed restriction of 20 minutes 
interview time per participant, were presented and discussed with the clinical manager and 
counselling staff. Upon approval for use by these staff members the following instruments 
were translated into Afrikaans and those translations checked by back-translation into 
English. 
 The Alcoholics Anonymous Affiliation Scale. 
With seven questions relating to affiliation with the AA/NA scale, this questionnaire is 
intended as a short and reliable assessment of participants’ levels of affiliation with AA (see 
Appendix A). ‘Yes’ and ‘no’ answers to these questions score respectively one or zero and 
are added together for a composite affiliation figure. Validity and reliability of the scale was 
tested on a sample of 927 alcohol treatment-seeking individuals from American public, 
private and health maintenance organizations (Humphreys, Kaskutas, & Weisner 1998). 
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Internal consistency of the scale was found to be high across every relevant population 
(Cronbach’s α = 0.85 in the treated sample and 0.84 in the untreated sample).  
Question 5 relates to a “spiritual awakening or conversion experience” which may 
possibly be construed as culture-specific. However, the preamble of AA includes a statement 
to the effect that AA does not affiliate itself with any “sect or denomination” and no 
particular spiritual entity is prescribed (Edwards et al., 1997, p. 274). 
Due to the treatment programme endorsing the importance of the principles of the AA 
and strongly encouraging attendance, this scale was chosen to indicate the level of affiliation 
with the AA of participants and that level’s association with abstinence or reduced substance 
use. 
Alcohol, Smoking and Substance Involvement Screening Test (WHO ASSIST 
V3.0). 
Designed by the World Health Organization to identify substance abuse problems worldwide, 
the Alcohol, Smoking and Substance Involvement Screening Test V3.0 (ASSIST) consists of 
a 10-minute 8-section self-administered pencil and paper questionnaire (see Appendix B). 
Respondents are assessed for risk related to tobacco, alcohol, cannabis, cocaine, 
amphetamine–type stimulants, inhalants, sedatives, hallucinogens, opiates and ‘other drugs’ 
(WHO, 2008) by responses to questions relating to substances used as well as personal 
problems encountered through their use. An additional category of Methaqualone (Mandrax) 
was added to the ASSIST questionnaire in this study in recognition of its perceived 
popularity, particularly in the Western Cape.  
The ASSIST is a standardized instrument which has successfully undergone testing 
for significance of feasibility, validity, reliability, flexibility, comprehensiveness, cross-
cultural relevance and its application in brief interventions. High validity findings include 
significant correlations between ASSIST scores and scores of other well-established similar 
measuring instruments. The ASSIST questionnaire was found to be a valid measure of 
severity of dependence for the substances deemed most problematic by the participant. 
Scores on the instrument measure whether respondents are at low, moderate or high risk of 
experiencing problems related to substance abuse. Significant correlations indicate that 
ASSIST’s low, moderate and high risk categories are good predictors of, respectively, 
substance use, substance abuse and substance dependence (Newcombe, Humeniuk, & Ali, 
2005) and may be referred to as such in this study.  
The ASSIST is considered a valid screening test for the identification of multiple 
substance use (Humeniuk et al., 2008). This incorporation of a broad range of drugs listed 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
45 
 
separately to comprehensively gauge levels of poly-substance use contributed to its choice as 
a measuring tool. Scores in response to question 2 for each substance: ‘in the past (applicable 
time period inserted), how often have you used the substance you mentioned?” were totalled 
and utilized as an indication of levels of drug use and abstinence. Categories of frequency of 
use are; Never, Once or Twice, Monthly, Weekly and Daily/Almost Daily. In addition to 
calculating severity of use of individual drugs a global ASSIST score was used to calculate 
the severity of dependence score in keeping with the use for which this questionnaire was 
originally intended. This was calculated by adding the total of all scores relating to drug 
problem severity (questions two to seven) for each drug but excluded responses to all 
questions relating to tobacco use. Questions relating to problem severity refer to urges to use, 
impact on health, social, legal and financial problems, failure to function ‘normally’, concern 
of others over use and success of previous attempts to cut down or stop using substances. 
This global ASSIST score was that used in all analyses except those specifically referring to 
scores of substance use only. All tests which were run with the global ASSIST score were 
duplicated using question 2 (substance use only) scores and obtained results similar in 
magnitude and direction. 
Although the Addiction Severity Index (ASI) Questionnaire is also an appropriate and 
comprehensive measurement tool, the interview time constraints discussed with the clinical 
manager dictated a need for a briefer instrument. Even the ASI-Lite was too long for the 
purposes of this study. However, Humeniuk et al. (2008) note significant correlations 
between ASI-Lite and ASSIST validity (r = 0.76-0.88) as well as finding significant 
correlations between ASSIST scores and measures of risk factors leading to the development 
of drug and alcohol problems (r = 0.48-0.76). The CAGE questionnaire, attractive for its 
brevity (four questions), does not measure use of different substances and is too 
comparatively abstract to allow for measurement of change as sensitive as the ASSIST. 
The instrument was tested for cross-cultural relevance (WHO, 2008) and has already 
been successfully utilized in a South African study involving substance abuse among South 
African primary care clinic patients (Ward et al., 2008), and in another exploring the extent 
and influence of recreational drugs in South Africa (Njuho & Davids, 2010).  
Due to budgetary constraints preventing toxicological screenings as confirmation of 
participants’ claims of abstention, reliance on self-report from participants was necessary. 
Confirmatory evidence of respondent reliability was discovered in a large sample of US 
Project MATCH, where it was found that participants’ self-reported drug use was highly 
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consistent with the results of urine drug screens (Project MATCH Research Group, 1997). 
Self-reported drug use was therefore considered acceptable in this study context. 
Socrates Stages of Change Readiness and Treatment Eagerness Scale 
(SOCRATES). 
The SOCRATES Stages of Change Readiness and Treatment Eagerness Scale developed by 
Miller and Tonigan (1996) was designed as a tool to assess levels of motivation for change in 
substance users in the three sub-scales of Problem Recognition, Ambivalence and Taking 
Steps Towards Change (see Appendix C). The scales were tested on sample populations 
already in treatment (Miller & Tonigan, 1996).  
The instrument consists of 19 items rated on a 5-point Likert-like scale divided into 
three sub-scales with relatively little overlap. The Recognition sub-scale assesses 
respondents’ self-perceptions of drinking problems. Recognition scores are positively 
associated with problem severity and high scores indicate acknowledgement of problems 
related to excessive drinking or drug use, while low scores reflect little or no desire for 
change.  
The Ambivalence sub-scale assesses a “weighing up” attitude towards change. A high score 
points towards uncertainty or ambivalence and openness to reflection about drinking or drug 
use. Low scores can either indicate that respondents think that they do not have a 
drinking/drug problem or “know” that their use of alcohol or drugs is a problem. Tonnigan 
and Miller (1996) warn against the possibility of ambiguous results on the Ambivalence scale 
for this reason. Interviewers are advised that low ambivalence scores with concurrent high 
recognition scores should be interpreted as high ambivalence levels. The ambivalence 
variable of each participant was therefore restructured in an attempt to remove this ambiguity 
and recoded as follows: If the ambivalence score was equal to 1 and the recognition score 
was either 4 or 5 then the ambivalence score was altered to 5. If the ambivalence score was 
equal to 2 and the recognition score was either 4 or 5 then the ambivalence score was 
changed to 4.  
The Taking Steps sub-scale assesses the level of action being taken by respondents to 
make positive changes to their drinking or drug use. High scores may predict successful 
change and the taking of active steps toward change.  
Instrument validity has been found to be strong in previous studies, as it makes use of 
two large data sources, namely from Project MATCH and the Project MATCH Reliability 
Study, both of which include a range of demographic and drinking variables that permit 
assessments of instrument validity. The SOCRATES scale demonstrates test-retest reliability 
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coefficients on all sub-scales based on these data sources. Cronbach’s α test-retest reliability 
for Ambivalence was .88 and .87 respectively; Recognition, .95 and .95 and Taking Steps, 
.95 and .96 (Miller & Tonigan, 1996). Due to the treatment programme’s underscoring of the 
importance of the stage of change of the client, this instrument was chosen as the best 
measure to ascertain participants’ motivational levels at the different time points.  
Drug-Taking Confidence Questionnaire-8 (DTCQ-8). 
Designed by Sklar and Turner (1999), this is a brief assessment of levels of coping self-
efficacy in substance abusers to gauge their belief that they are able to resist the temptation to 
drink or use drugs (see Appendix D). It is appropriate for use before, throughout and after 
treatment. It is derived from a 50-item questionnaire of the same name and is based on the 
premise that self-efficacy beliefs in relation to coping in this context are situation-specific 
and identifies relapse precipitants. These fall into the categories of unpleasant emotions, 
physical discomfort, pleasant emotions, testing personal control, urges and temptations to 
use, conflict with others, social pressure to use and pleasant times with others. Validity and 
reliability of the instrument is good, and compared against the 50 item drug-taking 
confidence questionnaire, evaluates global self-efficacy with 95% accuracy. It is reported as a 
particularly appropriate tool in telephone follow-ups (Sklar & Turner, 1999). This, combined 
with an aim of MI counselling to improve levels of self-efficacy, makes it a suitable 
measuring instrument for this study’s purposes.  
Client Satisfaction Questionnaire. 
This questionnaire comprises seven close-ended questions and one open-ended question 
devised by the clinical manager and director of the Centre (see Appendix E). The number of 
items was limited due to time and budgetary constraints. Questions relate to clients’ 
assessment of staff sensitivity, turn-around time of service-delivery and perception of 
programme efficacy. The final question asks for ideas for improvement of the programme. 
These results are tabulated and retained in this study for Centre management information 
only as the instrument is not standardized and has not been tested for validity or reliability. 
Sample and Participant Selection 
Permission was sought and given to obtain access to participants’ client records for the 
purposes of the project. A convenience sample was used due to the restrictive design 
parameters of this study. As the proportion of clients who arrive for their first appointments 
varies and some clients may arrive without prior appointment, participants were recruited at 
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their point of admission into the Centre’s treatment programme and were interviewed prior to 
their intake assessment interview with Centre counsellors. 
Inclusion and exclusion criteria. 
Inclusion criteria were a minimum age of 18 years with no upper age limit, as well as alcohol 
or substance abuse or dependence and active substance use or drinking during at least the 
three months before initial intake. Alcohol and drug abuse levels were determined by the 
ASSIST scale. An exclusion criterion was being considered a danger to self or others by 
Centre staff, although no one fell into this category. Any participant referred to in-patient 
treatment at any stage of the study was excluded, as the Centre’s treatment effects would be 
obfuscated by the effects of the in-treatment facility.  
Procedure 
Agreement was reached with clinical management that interviews should, as far as possible, 
be restricted to a maximum of 20 minutes in length and appropriate procedures relating to 
recruitment and participation were discussed and agreed upon. On each of the twice-weekly 
morning admission clinics, clients were approached by a staff member, informed of the 
research project underway and asked whether they would be interested in participating in the 
study. No incentives were offered to participants. If in agreement, they were introduced to the 
researcher who explained the project and described the interviewing and follow-up process in 
more detail. Both the researcher and participant then reviewed the consent form together to 
ensure understanding of the content (see Appendix F). The elements of voluntary 
participation and freedom to refuse to participate without impact on their treatment 
programme were emphasized to participants at all times. All participants were informed that a 
research report would be available at the Centre for perusal in 2013, an arrangement 
approved of by the Centre’s clinical manager. All of the above information is clearly stated in 
the consent form, which provides contact details for further information or complaints about 
circumstances pertinent to this study. Identifying information on the consent form and data 
collection forms were kept in separate locked cupboards in the home of the researcher and 
not made available to anyone other than the researcher and her assistant. Data was stored on 
two separate flash drives and when not in use, kept with the data collection forms under lock 
and key. No study participants are identifiable in this report and the entire study was 
conducted within strict parameters of confidentiality and anonymity. 
 On admission, all questionnaires described in this report were administered in a 
standardized format in the order of SOCRATES, DTCQ-8, ASSIST and NA/AA Affiliation 
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with a few exceptions: After nine interviews and comments from three clients indicating 
surprise at their high levels of substance use after completion of the ASSIST questionnaire, 
which initially headed the order of administration, SOCRATES was moved to first position. 
This was to obviate the possibility of the ASSIST questionnaire acting as an independent 
motivational mechanism, similar to the feedback process in motivational enhancement 
therapy, and increasing awareness and discrepancy as described by Miller & Rollnick (1991). 
This could also possibly compromise admission data on the SOCRATES sub-scales of 
Recognition and Ambivalence. Due to time management concerns of Treatment Centre staff 
the first 13 clients were interviewed only after completion of their initial assessment session 
with their allocated counsellors. This procedure was revised to ensure participants were 
interviewed prior to their assessment due to the same concerns relating to compromised 
responses to the SOCRATES questionnaire. All SOCRATES data pertaining to the first 13 
participants were therefore treated as missing but other information was retained. 
Questionnaires were telephonically re-administered at six weeks after admission and ten 
weeks after admission. 
Sample 
A total of 261 participants completed admission interviews during the period 24 May 2011 
until 3 April 2012. Of these, 56 were assessed but did not enter treatment and were therefore 
excluded from this study. During the course of this study, 47 participants were referred by the 
Centre to in-patient facilities, seven entered alternative treatment under their own 
arrangements, four spent more than three days in a psychiatric facility, while five were 
imprisoned during the follow-up period making the total number of clients eligible for study 
198 (see Table 2). No data relating to these participants from already completed follow-up 
interviews were retained and no interviews performed if the alternative treatment was 
undergone at any time during the designated 10-week follow-up period. 
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Table 2 
Sample Distribution 
   
    Category Analysis Frequency Percent 
Included in study:    
Entered treatment programme Included 142 54.41 
Assessment only Baseline only 56 21.46 
Subtotal  198  
Not included in study:    
Referred by Centre to in-patient facility Excluded 47 18.01 
Self-referred to in-patient facility Excluded 7 2.68 
More than 3 days in psychiatric ward Excluded 4 1.53 
Imprisoned during follow-up period Excluded 5 1.92 
Subtotal  63  
Total 
 
261 100 
 
Follow-up  
A minimum of six telephone calls was made to each participant on different days and at 
different times of the day within a window period of 14 days after each follow-up date, until 
they were either reached and interviewed, or it was determined that they could not be 
contacted by telephone. These calls were made to clients’ personal mobile telephones and 
home telephones as well as to significant others designated by clients as allowable contacts. 
Communication details of elusive clients were double-checked at the Centre. Some clients 
were homeless and consequently incommunicado due to having dropped out of the treatment 
programme, or did not own their own mobile telephones and were dependent on others’ good 
offices in conveying messages or arranging to speak at certain times. Still others had referred 
themselves to in-patient treatment facilities. Only one participant refused to complete 
questionnaires once contacted.  
Seven clients refused to participate in the project and another six were excluded 
before an admission interview due to symptoms of psychosis impacting on comprehension 
levels. One client, obviously and self-admittedly under the influence of a mind-altering 
substance during the interview, was also excluded.  
A total of 245 interviews were conducted at 6 weeks post-admission and 10 weeks 
post-admission with 88 participants completing interviews at all three time points and 10 
participants completing interviews at admission and 10 weeks post-admission only, making 
98 participants in all who completed questionnaires at admission and ten weeks after 
admission (see Table 3).  
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Table 3 
Follow-Ups for In-Treatment Group 
  
 
  
   
 
  Category Freq.  Percent 
Admission only, no follow-up interviews 27    19%   
Admission and 6 weeks interviews only 17 
 
 12% 
 Admission and 10 weeks interviews only 9 
}  
 6% 
} 69%* 
Admission, 6 and 10 weeks interviews only  89 
98* 
63% 
Total 142    100%   
*Note. Interviewed at Admission and 10 Weeks Post-Admission 
 
Data Analyses 
 Full in-treatment sample analysis (N=142) 
Three analyses were performed on the in-treatment sample. The first, on the full in-treatment 
sample (N=142), compared measures at admission and 10 w eks post-admission, with 
admission values imputed for missing data at 10 weeks post-admission, following an intent-
to-treat approach to analysis (Shadish et al., 2002). Although Digiusto et al. (2006) conclude 
in their study relating to follow-up difficulty in a heroin abusing population that imputing 
baseline data for missing outcomes data may be too conservative, this procedure was 
followed for various reasons. As there is a perception that drug abusers drop out of a 
programme due to a return to drug abuse (Shadish et al., 2002), the use of some of the 
common alternative imputation procedures could potentially yield results perceived to be 
biased towards favourable outcomes. Therefore the imputation procedure of mean 
substitution, where every missing value is replaced by the mean value of the relevant 
variable, was precluded. For the same reason regression substitution, where missing values 
are replaced by the predicted value of that variable from a regression analysis using cases 
with no missing data (Rosenthal & Rosnow, 2008), was rejected in favour of imputing 
baseline data.  
Analysis on data collected at two time points of admission and 10 weeks post-
admission (n=98) 
Another analysis was performed on data obtained from the next largest group of participants 
(n=98), who were interviewed on admission and at 10 weeks post-admission and who 
comprised 69% of the full in-treatment sample. A comprehensive study with a sample size of 
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654 participants examines the effects of different follow-up rates on estimates of substance 
treatment outcome and relative predicative models. Findings include that outcome estimates 
of the easiest participants to locate (within 10 days), amounted to 60% of study participants 
and differed only minimally to those of the additional 30% of the sample who were located 
within the full three month window follow-up period (Hansten, Downey, Rosengren, & 
Donovan, 2000). Another study argues that a 70% follow-up rate is an appropriate level of 
response at which the possibility of error in generalizing findings to the remainder of the 
sample is markedly reduced (Digiusto, Panjari, Gibson, & Rea, 2006; Hubbard, Craddock, 
Flynn, Anderson, & Etheridge, 1997) with Digiusto et al. claiming a less than 5% error rate in 
the same context. A feasibility study of low-budget telephonic follow-up interviews in a 
substance abuse outcomes monitoring context, reports even the 53% response rate achieved 
on that sample as modest yet acceptable (Oudejans, Schippers, Merkx, Schramade, Koeter, & 
Brink, 2009). 
Clearly there is disagreement regarding follow-up rates sufficiently feasible to 
generalize findings to the remainder of the sample in the context of substance use. However, 
the percentage follow-up rate of 69% at 10 weeks post-admission in this study falls only 
marginally short of the most conservative parameter of a 70% follow-up rate requirement by 
Digiusto et al. (2006) and Hubbard et al. (1997), and well within the >60% follow-up rate 
prerequisite for inference by Hansten et al. (2000). Further findings of this study include that 
if the difficult-to-track participants had been treated as lost subjects and baseline data inserted 
at the follow-up point, substantially greater errors would have occurred than those produced 
in estimates based on actual reported values of the 60% followed up group.   
It therefore seemed appropriate, with this high follow-up rate of 69%, to analyze the 
data for the 98 participants; this would enable an analysis without imputed data for 
participants who both received the programme and were contacted at follow-up, as a 
comparison to the intention-to-treat analysis. 
Analysis on data collected at the three time points of admission, 6-weeks post-
admission and 10-weeks post-admission (n=89)  
Although 10 week post-admission follow-up information was considered a better barometer 
of success than 6 week post-admission data alone, the trajectory of levels of substance use 
during and after treatment and the interaction effects of the other variables under study at 
both follow-up times were of interest. A third analysis was therefore performed on the 89 
participants who completed all three interviews (admission, 6 week post-admission and 10 
week post-admission). This analysis was restricted to ascertaining whether time-related 
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trends in this study context exist due to the lower follow-up rate of 63% for all three time 
points and the consequently weaker inference potential of the analysis. The only other test 
run on this sample was to check for an association between global ASSIST scores at 10 
weeks post-admission and self-efficacy scores at 6 weeks post-admission, in keeping with 
claims by Sklar and Turner (1999) that a strong negative inverse relationship exists between 
self-efficacy at end of treatment and reduced substance use. 
All variables were slightly skewed. Given the repeated measures and the requirement 
of the inclusion of covariates, non-parametric methods of assessment were precluded. 
However, to ensure that potentially significant results obtained from parametric tests were not 
misleading, measurement data was replaced by its numerical rank from highest to lowest, and 
regressions were re-run on ranked values of each variable with robust results. 
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CHAPTER FIVE 
Results 
Baseline Characteristics 
Clients of the Centre who enrolled in the study ultimately fell into two groups (see Table 4): 
Participants who only attended the assessment (n=56), and another which comprised 
participants who attended any treatment sessions (n=142). These groups were treated 
separately in some analyses.  
Males were by far in the majority in both In-Treatment and Assessment-Only groups 
(75%; 86%). Only 18% of females were lost after assessment compared to 31% of males 
although this difference was not found to be significant. Although representation of Black 
participants was low in both groups (In-Treatment: 14%, Assessment-Only: 9%), retention 
rates were comparatively good, with 20% lost after assessment in that group compared to 
32% of Coloured participants and 24% of Whites, none of which compared differences were 
significant. Coloured participants comprised by far the majority in both In-Treatment (61%) 
and Assessment-Only (71%) groups. Mean age was 30.23 (SD=9.71) for In-Treatment and 
27.95 (SD=7.63) for Assessment-Only groups. NA/AA affiliation was low with a median of 
0.  
Comparative baseline drug use. 
Differences between drug use in groups at baseline were significant in the High-Risk Opioid 
category with 13% of In-Treatment participants’ heroin use falling into that category but 34% 
of Assessment-Only participants in the same (  (df=1)=11.938, p=0.001) (see Table 5). 
Methamphetamine high risk use was conversely significantly different at baseline with  39% 
of In-Treatment participants falling into the High-Risk category but only 23% of Assessment-
Only participants reporting the same (  (df=1)=4.289, p=0.027). There were no significant 
differences comparing use of the other drugs at high-risk levels between the two groups at 
baseline. Low-risk levels of alcohol use were reported in high proportions for both In-
Treatment and Assessment-Only groups at 38% and 50% respectively. Use of cannabis and 
mandrax in both groups at medium-risk levels were reported in relatively high proportions:  
In-Treatment participants reported 39% cannabis and 17% mandrax use at this level and 
Assessment-Only participants reported 46% cannabis and 27% mandrax at the same level. 
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Cocaine use in both baseline groups was fairly high with 8% of In-Treatment participants and 
11% of Assessment-Only participants reporting use in the High-Risk category. Both groups 
showed extremely low use of sedatives, hallucinogens, inhalants and ‘other’ drugs. 
Sixty percent of In-Treatment participants and 57% of Assessment -Only participants 
reported use of only one drug in the High-Risk category but both groups reflect considerable 
polysubstance use (see Table 6). The Assessment-Only group was markedly higher in use of 
three or more substances in the Medium-Risk category (27%) than that of the In-Treatment 
group (15%). This difference approached significance at the 5% level (  (df=1)=3.371, 
p=0.066). The Assessment-Only group also reflected more participants using substances in at 
least two Medium-Risk categories and one in a High-Risk category (32%) than those in the 
In-Treatment group (25%), although this difference was not significant. Similarly, the 
Assessment-Only group also reflected more participants using substances in at least two 
High-Risk categories (20%) than those in the In-Treatment group (18%), but not at 
significantly different levels. 
Attendance 
Clients were spread across the attendance continuum from “attended all compulsory lectures 
and group and individual sessions” to “attended no lecture or group or individual session after 
the first assessment”. Due to attendance of voluntary sessions after completion of the 
programme, 8% of clients attended more than 100% of the required sessions (See Table 7). 
Fifteen percent of participants attended from 50% to 75% of all sessions and 20% attended 
from 76% to 100% of all sessions (see Appendix G for separate tables of individual, group 
and lecture sessions attended). 
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Table 4 
Characteristics of Participants at Baseline 
                     
 
 
In-Treatment Assessment-Only Proportional 
Loss Demographics Mean (SD) N % Mean (SD) N % 
Total number participants 
 
142 100 
 
56 100 
 
    Female  
 
36 25 
 
8 14 18% 
    Male 
 
106 75 
 
48 86 31% 
Age  30.23 (9.71) 
  
27.95 (7.63) 
   
Race 
         Coloured 
 
86 61 
 
40 71 32% 
  Black 
 
20 14 
 
5 9 20% 
  White 
 
34 24 
 
11 20 24% 
  Unknown 
 
2 1 
 
0 0 0% 
Peer Programme: NA/AA 
          Median (Range) NA/AA Affiliation 0 (0-7) 
  
0 (0-6) 
      Median (Range) number of meetings monthly  0 (0-90) 
  
0 (0-50) 
   
   Median (Range) number of meetings for the past 12 months 0 (0-210) 
  
0 (0-144) 
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Table 5 
                Substance Use History for all Participants 
at Admission                
                 In-Treatment Risk Category of Use   Assessment-Only Risk Category of Use 
Grand 
Total 
 
 (n = 142) 
 
(n = 56) 
  None % Low % Medium % High % 
 
None % Low % Medium % High % 
Methamphetamines  50 35% 3 2% 34 24% 55 39% 
 
24 43% 2 4% 17 30% 13 23% 198 
Opioids 114 80% 2 1% 8 6% 18 13% 
 
30 54% 0 0% 7 13% 19 34% 198 
Alcohol 39 27% 54 38% 22 15% 27 19% 
 
14 25% 28 50% 7 13% 7 13% 198 
Cannabis 53 37% 14 10% 50 35% 25 18% 
 
16 29% 4 7% 26 46% 10 18% 198 
Cocaine 104 73% 8 6% 19 13% 11 8% 
 
37 66% 2 4% 11 20% 6 11% 198 
Mandrax 105 74% 6 4% 24 17% 7 5% 
 
33 59% 2 4% 15 27% 6 11% 198 
Sedatives 124 87% 3 2% 8 6% 7 5% 
 
48 86% 1 2% 6 11% 1 2% 198 
Other 138 97% 1 1% 1 1% 2 1% 
 
54 96% 1 2% 1 2% 0 0% 198 
Inhalants 138 97% 2 1% 2 1% 0 0% 
 
50 89% 4 7% 1 2% 1 2% 198 
Hallucinogens 128 90% 2 1% 12 8% 0 0% 
 
48 86% 2 4% 6 11% 0 0% 198 
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Table 6 
 
 
Table 7 
 
Total Sessions Attended for Those in Treatment 
    Treatment dosage as % (of the 18 treatment 
components) Freq. Percentage 
Cumulative 
Percentage 
<25% 50 35% 35% 
26-50% 30 21% 56% 
51-75% 22 15% 72% 
76-100% 29 20% 92% 
>100% 11 8% 100% 
Total 142 100% 
 
 
Full In-Treatment Sample Analyses (N=142) 
On this sample of all participants retained for treatment baseline data per case for all missing 
values was imputed, and a mixed effect simple regression analysis was performed (see Table 
8) to ascertain the impact of time on the global ASSIST score which was significant. The 
global ASSIST score decreased by 29 units on average from admission to 10-weeks post-
admission.  
 
Substance Use at Admission by Risk Category 
    
    In-Treatment 
(n=142) 
Assessment-
Only (n=56) 
Category Value Frequency % Frequency % 
High-Risk  At least two or more substances in high-risk 
categories 26 18% 11 20% 
One substance in a high-risk category 85 60% 32 57% 
No substance in a high-risk category 31 22% 13 23% 
Medium-Risk At least three or more substances in medium-
risk categories 22 15% 15 27% 
Two substances in a medium-risk category 29 20% 10 18% 
One substance in a medium-risk category 37 26% 17 30% 
No substance in a medium-risk category 54 38% 14 25% 
Mixed At least two medium-risk categories and one in 
a high-risk category 35 25% 18 32% 
No substance in medium- or high-risk 
categories 1 1% 0 0% 
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Table 8 
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 56.89 2.80 141.00 20.29 .000 51.35 62.44 
Time -29.07 3.80 279.88 -7.64 .000 -36.56 -21.58 
 
Mixed effect simple regressions were run on each variable in turn to observe independent 
changes over time as displayed in Tables 9 to 13. Self-efficacy scores and SOCRATES 
Taking Steps increased significantly from admission to 10 weeks post-admission. 
SOCRATES Ambivalence scores decreased significantly over the same period. There was no 
significant effect of time on either AA affiliation or SOCRATES Recognition scores. 
 
Table 9 
Regression Results for Imputed Data Analyses (N=142): Self-Efficacy vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 348.18 12.84 141.00 27.11 .000 322.79 373.57 
Time 112.07 21.76 258.25 5.15 .000 69.22 154.92 
 
 
Table 10 
Regression Results for Imputed Data Analyses (N=142): NA/AA Affiliation vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 1.13 .15 141.00 7.29 .000 .82 1.43 
Time .25 .23 277.81 1.09 .278 -.21 .71 
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Table 11 
Regression Results for Imputed Data Analyses (N=142): SOCRATES Recognition vs. Time   
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 32.04 0.38 136.00 84.24 .000 31.28 32.79 
Time -1.15 0.61 257.88 -1.86 .063 -2.36 0.06 
 
Table 12 
Regression Results for Imputed Data Analyses (N=142): SOCRATES Taking Steps vs. Time  
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 35.30 0.42 136.00 83.99 .000 34.47 36.13 
Time 1.45 0.56 268.70 2.56 .011 0.34 2.56 
 
Table 13 
Regression Results for Imputed Data Analyses (N=142): SOCRATES Ambivalence vs. Time  
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 83.18 0.83 136.00 100.55 .000 81.55 84.82 
Time -23.65 3.49 152.09 -6.77 .000 -30.55 -16.75 
 
Mixed effect multiple regression analyses were also conducted to determine the impact of the 
different covariates on the global ASSIST score in conjunction with time (see Appendix H, 
Tables H1-H7). Dosage (i.e. the amount of treatment to which the participant had been 
exposed to) had a significant impact on the global ASSIST score which decreased by 16 units 
on average when the dosage increased by 1%. Similarly, the average decrease in the global 
ASSIST score of 0.06 units when the self-efficacy score increased by 1 unit is significant, 
although there was no significant interaction between self-efficacy scores and time: i.e. the 
inverse relationship between self-efficacy and global ASSIST scores did not change from 
admission to 10 weeks post-admission and the effect of self-efficacy on the global ASSIST 
score did not depend on the level of time and vice versa. 
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 The SOCRATES Taking Steps score had a significant effect on the global ASSIST 
score which decreased by 1.55 units on average when the SOCRATES Taking Steps score 
increased by 1 unit. Similarly, the SOCRATES Recognition score had a significant effect on 
the global ASSIST score which increased by 1.01 units on average when SOCRATES 
Recognition increased by 1 unit. The SOCRATES Ambivalence score had a significant effect 
on the global ASSIST score which decreased by 0.44 units when the SOCRATES 
Ambivalence score increased by 1 unit. There was no significant interaction for any of the 
SOCRATES sub-scales by time.  
As previous clean time had no impact on the global ASSIST score over time, nor 
NA/AA affiliation; only dosage, self-efficacy, SOCRATES Taking Steps, SOCRATES 
Recognition and SOCRATES Ambivalence scores were included in a final model for global 
ASSIST (together with time). This was to establish the relative impact of variables already 
shown to significantly influence the global ASSIST score over time without the potentially 
confounding addition of variables of no significance in the analysis.  
The multiple mixed effects regression (see Table 14) which controls for potential 
confounders and calculates the relative contribution of each independent variable of each of 
the significant variables revealed the following: Time had a significant impact on the global 
ASSIST score which decreased by 33 units on average when comparing 10 weeks post-
admission to admission. The impact of dosage was significant: The global ASSIST score 
decreased by 10.2 units on average when the dosage increased by 1%. Self- efficacy had a 
significant impact on the global ASSIST score which decreased by 0.03 units on average 
when self-efficacy increased by 1 unit. SOCRATES Taking Steps had a significant impact on 
the global ASSIST score which decreased by 0.75 units on average when SOCRATES 
Taking Steps increased by 1 unit. SOCRATES Recognition also had a significant impact on 
the global ASSIST score which increased by 1.47 units on average when SOCRATES 
Recognition increased by 1 unit. Lastly, SOCRATES Ambivalence had a significant impact 
on the global ASSIST score which decreased by 0.37 units on average when SOCRATES 
Ambivalence increased by 1 unit. 
Finally, to ascertain any association between changes in global ASSIST scores at 10 
weeks post-admission against admission scores of relevant variables, a Spearman correlation 
test was conducted. No significant impact was found by self-efficacy levels, SOCRATES 
Taking Steps, SOCRATES Ambivalence and SOCRATES Recognition on the 10 week 
global ASSIST score.  
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Table 14 
Regression Results for Imputed Data Analyses (n=142): Predicting substance misuse 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 81.49 13.47 229.40 6.05 .000 54.94 108.04 
Time -32.70 3.79 261.71 -8.63 .000 -40.16 -25.24 
Dosage -10.20 4.22 230.83 -2.42 .016 -18.52 -1.89 
Self-efficacy -0.03 0.01 190.47 -3.38 .001 -0.04 -0.01 
SOCRATES Taking Steps -0.75 0.38 252.22 -1.97 .050 -1.51 0.00 
SOCRATES Recognition 1.47 0.31 197.57 4.77 .000 0.86 2.08 
SOCRATES Ambivalence -0.37 0.05 144.59 -7.27 .000 -0.47 -0.27 
Analyses on Data Collected at Two Time Points of Admission and 10 Weeks Post-
Admission (n=98) 
A mixed effect simple regression analysis was performed to ascertain the impact of time  
on the global ASSIST score which was significant and decreased by 42.12 units on average 
when comparing 10 weeks post-admission to admission (see Table 15).  
 
Table 15 
 
 
 Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs.  
Time 
 
      
95% Confidence Interval 
Parameter Estimate Std. Error df t p Lower Bound 
Upper 
Bound 
Intercept 56.33 3.52 97 16 0 49.34 63.31 
Time -42.12 4 148.7 -10.54 0 -50.02 -34.23 
 
 Mixed effect simple regressions were run on each variable in turn to observe independent 
changes over time as shown in Tables 16 to 20. Self-efficacy scores increased significantly 
from admission to 10 weeks post-admission as did SOCRATES Taking Steps while 
SOCRATES Recognition scores decreased significantly over the same time period.  
 
Table 16 
 
Regression Results for Non-Imputed Data Analyses (n=98): Self-Efficacy vs. Time 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 352.15 15.99 97.00 22.02 .000 320.41 383.90 
Time 162.39 26.77 179.34 6.07 .000 109.57 215.21 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
63 
 
 
Table 17 
Regression Results for Non-Imputed Data Analyses (n=98): AA Affiliation vs. Time 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 1.15 .19 97.00 6.06 .000 .78 1.53 
Time .37 .29 189.37 1.25 .212 -.21 .95 
 
Table 18 
Regression Results for Non-Imputed Data Analyses (n=98): SOCRATES Recognition vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound 
Upper 
Bound 
Intercept 32.24 0.48 96.00 67.13 .000 31.28 33.19 
Time -1.62 0.80 178.43 -2.03 .044 -3.19 -0.04 
 
Table 19 
Regression Results for Non-Imputed Data Analyses (n=98): SOCRATES Taking Steps vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 35.55 0.49 96.00 72.60 .000 34.57 36.52 
Time 2.04 0.62 181.30 3.29 .001 0.82 3.27 
 
Table 20 
Regression Results for Non-Imputed Data Analyses (n=98): SOCRATES Ambivalence vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 83.58 1.03 96.00 80.90 .000 81.53 85.63 
Time 0.51 1.62 185.37 0.31 .756 -2.70 3.71 
 
Mixed effect multiple regression analyses were also conducted to determine the impact of 
different covariates on the global ASSIST score, in conjunction with time (see Appendix I, 
Tables I1-I7). Dosage had a significant impact on the global ASSIST score which decreased 
by 9.52 units on average when the dosage increased by 1%. The average decrease in the 
global ASSIST score of 0.03 units when the self -efficacy score increased by 1 unit was also 
significant. There was no significant interaction between self-efficacy scores and time. The 
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SOCRATES Taking Steps score had a significant effect on the global ASSIST score which 
decreased by 0.94 units on average when SOCRATES Taking Steps increased by 1 unit. The 
SOCRATES Recognition score had a significant effect on the global ASSIST score which 
increased by 0.57 units on average when SOCRATES Recognition increased by 1 unit. There 
was no significant interaction between SOCRATES Recognition or taking steps scores and 
time. As neither previous clean time, NA/AA affiliation nor SOCRATES Ambivalence had a 
significant impact on the global ASSIST score over time, only the variables of dosage, self-
efficacy, SOCRATES Taking Steps and SOCRATES Recognition were included in a final 
model for global ASSIST (together with time).  
A multiple mixed effects regression looking at the adjusted effect of each of the 
significant variables revealed the following (see Table 21): Time had a significant impact on 
the global ASSIST score which decreased by 34.55 units on average when comparing 10 
weeks post-admission to admission. Dosage approached significance at the 5% level (t= -
1.811, p=0.072): The global ASSIST score decreased by 7.44 units on average when the 
dosage increased by 1%. Self-efficacy had a significant impact on the global ASSIST score 
which decreased by 0.02 units on average when self-efficacy increased by 1 unit. 
SOCRATES Taking Steps had a significant impact on the global ASSIST score which 
decreased by 1.37 units on average when SOCRATES Taking Steps increased by 1 unit. 
Lastly, SOCRATES Recognition also had a significant impact on the global ASSIST score 
which increased by 1 unit on average when SOCRATES Recognition increased by 1 unit. 
To establish whether an association existed between changes in global ASSIST scores at 10 
weeks post-admission against admission scores of relevant variables, a Spearman correlation 
test was conducted. No significant impact was found by self-efficacy, SOCRATES Taking 
Steps, SOCRATES Ambivalence, SOCRATES Recognition or NA/AA affiliation on the 10 
week post-admission global ASSIST score. However, the impact of previous clean time at 
admission on the 10 week post-admission global ASSIST score (rho= -0.1933, p=0.0711) 
approached significance at the 5% level. 
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Table 21 
 
Regression Results for Non-Imputed Data Analyses (n=98): Predicting substance misuse 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 84.19 14.48 161.97 5.81 .000 55.60 112.79 
Time -34.55 4.18 157.59 -8.27 .000 -42.80 -26.30 
Dosage -7.44 4.11 140.26 -1.81 .072 -15.56 0.68 
Self-efficacy -0.02 0.01 113.50 -2.57 .011 -0.04 0.00 
SOCRATES Taking Steps -1.37 0.47 174.49 -2.94 .004 -2.30 -0.45 
SOCRATES Recognition 1.00 0.30 134.07 3.30 .001 0.40 1.60 
  
Substance use levels.  
Of the 98 participants interviewed at 10 weeks post-admission, 46 reported complete 
abstinence. Changes in substance use (see Table 22) revealed large percentage reductions 
across most substances: Notably,mandrax with a 95% reduction in use, then heroin with an 
89% reduction in use and methamphetamine use reduced by 73%. Use of cannabis reduced 
by 68% while alcohol reduced by the lowest percentage: 41%. 
 
Table 22 
Changes in  Substance Use per Substance  
      Using 
 
Number % 
Change Substance Admission 10 
Weeks 
Alcohol 68 40 41% 
Cannabis 56 18 68% 
Cocaine 19 3 84% 
Amphetamines 55 15 73% 
Inhalants 2 0 100% 
Sedatives 13 2 85% 
Hallucinogens 7 1 86% 
Opioids 18 2 89% 
Other 1 0 100% 
Mandrax 21 1 95% 
 
Comparative frequency of use of all substances between admission and 10 weeks post-
admission (see Table 23) was checked. Most values decreased in all the frequency of use 
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categories and increased in the abstinence (Never) category. The Daily/Almost Daily 
category reflects large percentage decreases across all substances with 100% reduction in use 
of cocaine, sedatives, opioids and other drugs. Notably, however, alcohol use in the 
Once/Twice category of the ASSIST measuring instrument increased by 50%. 
After excluding the 46 abstinent participants at 10 weeks post-admission it was 
established that the remaining 52 non-abstinent participants reduced their substance use 
significantly but the anomaly of increased occasional alcohol use in the Once/Twice category 
warranted further investigation. Of these 52 non-abstinent participants at 10 weeks post-
admission, thirteen participants had reported use of only alcohol once or twice at 10 weeks 
follow-up with no other substance use reported (see Appendix J, Table J1). Of these, eight 
had reported use of at least methamphetamine at admission, and five had reported use of at 
least cannabis at admission. These results instigated similar enquiry in the Weekly Use 
category for only alcohol use, into which six more participants fell (see Appendix J, Table 
J2), with three reporting at least methamphetamine use at admission and four at least 
cannabis use at the same time.  
For the sake of clarity, three overall levels of substance use at 10 weeks post-
admission were calculated. The first included only the 46 participants who reported complete 
abstinence from any substance at all (47%). Secondly, the 13% of participants, who had 
drunk alcohol once or twice over the four weeks prior to the 10 week follow-up interview, 
were added to the 46 abstinent participants. This created a group comprising 60% of all 
participants: Either Abstinent or Used Alcohol Once or Twice. Then the 6% of participants 
who reported weekly use of alcohol were added to that group and a new group was formed: 
Abstinence and Alcohol Use Weekly or Less, which totalled 66% of all participants. 
A Wilcoxon signed-rank test for the remaining 33 participants was performed which 
established that reduction use in this group was significant. A check of frequency of use (see 
Table 24) revealed a reduction of harm trend in that methamphetamine use was less frequent 
than at admission with a 73% reduction of use in the Daily/Almost Daily category, 25% 
reduction in the Weekly Use category and an increase of 200% in the Once or Twice 
category. Similarly, cannabis showed a daily use reduction of 58% while weekly use 
increased by 100%. The two participants who reported use of heroin only used the substance 
once or twice in the period before follow-up.    
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Table 23 
Changes in Substance Use Frequencies for all 98 Participants 
               Never Once/Twice Weekly Daily/Almost Daily 
 
Number % 
Change 
Number % 
Change 
Number % 
Change 
Number % 
Change Substance Admission 10 
Weeks 
Admission 10 
Weeks 
Admission 10 
Weeks 
Admission 10 
Weeks 
Alcohol 30 58 93% 16 24 50% 24 12 -50% 18 4 -78% 
Cannabis 42 80 90% 13 9 -31% 11 4 -64% 25 5 -80% 
Cocaine 79 95 20% 9 2 -78% 5 1 -80% 2 0 -100% 
Amphetamines 43 83 93% 10 9 -10% 12 3 -75% 26 3 -88% 
Inhalants 96 98 2% 2 0 -100% NA NA NA NA NA NA 
Sedatives 85 96 13% 5 2 -60% 4 0 -100% 2 0 -100% 
Hallucinogens 91 97 7% 6 1 -83% 2 0 NA NA NA NA 
Opioids 80 96 20% 2 2 0% NA NA -100% 14 0 -100% 
Other 97 98 1% NA NA NA NA NA NA 1 0 -100% 
Mandrax 77 97 26% 6 0 -100% 5 0 -100% 7 1 -86% 
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Table 24 
Changes in Substance Use Frequencies for 33 Remaining Participants 
               Never Once/Twice Weekly Daily/Almost Daily 
 
Number % 
Change 
Number % 
Change 
Number % 
Change 
Number % 
Change Substance Admission 10 
Weeks 
Admission 10 
Weeks 
Admission 10 
Weeks 
Admission 10 
Weeks 
Alcohol 8 12 50% 7 11 57% 9 6 -33% 2 4 100% 
Cannabis 7 15 114% 7 9 29% 2 4 100% 12 5 -58% 
Cocaine 23 30 30% 4 2 50% 4 1 -75% NA NA NA 
Amphetamines 14 18 29% 3 9 200% 4 3 -25% 11 3 -73% 
Inhalants 31 33 6% 2 0 -100% NA NA NA NA NA NA 
Sedatives 28 31 11% 2 2 0% 1 0 -100% 2 0 -100% 
Hallucinogens 30 32 7% 3 1 -67% NA NA NA NA NA NA 
Opioids 26 31 19% 1 2 100% 2 0 -100% 4 0 -100% 
Other 33 33 0% NA NA NA NA NA NA NA NA NA 
Mandrax 20 32 60% 5 0 -100% 4 0 -100% 2 1 -50% 
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Of the 33 participants not accounted for in the abstinence and alcohol use groups, 52% 
reported a 51%-99% reduction in their substance use (see Table 25). Reporting between 26% 
and 50% reduction in substance use were 27% of respondents. Two participants showed no 
change in their substance use while two increased their frequency of substance use by 1%-
20%.  
Table 25 
Percentage  Change in Substance Use from Admission to 10 Weeks Post 
Admission (n=33) 
    % Change category Freq. Percent           Cum. 
No change 2 6.06 6.06 
1%-20% Increase 2 6.06 12.12 
0%-25% Decrease 3 9.09 21.21 
26%-50% Decrease 9 27.27 48.48 
51%-75% Decrease 15 45.45 93.94 
76%-99% Decrease 2 6.06 100 
Total 33 100 
  
Analyses on Data Collected at the Three Time points of Admission, 6-Weeks Post-
Admission and 10-Weeks Post-Admission (n=89)  
This was the smaller section of the sample comprising participants who were contacted at all 
three time points. The trajectory of global ASSIST and substance use scores are displayed in 
figure 3. A mixed effect simple regression analysis was performed to ascertain the impact of 
time on the global ASSIST score and the substance use score at all three time points. The 
global ASSIST score significantly decreased between 10 weeks post-admission to admission 
by 42.12 units on average and significantly decreased by 39.21 units on average when 
comparing 6 weeks post-admission to admission. No significant difference was found 
between global ASSIST scores at 6 and 10 weeks post-admission (see Appendix K, Table K1 
and Table K2). The substance use score significantly decreased between 10 weeks post-
admission to admission by 9.06 units on average and also significantly decreased by 8.91 
units on average when comparing 6 weeks post-admission to admission. Again, no significant 
difference was found between substance use scores at 6 and 10 weeks post-admission (see 
Appendix K, Table K3 and Table K4). 
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Figure 3: Average Global ASSIST  and Substance Use Scores 
 
 
 
Mixed effect multiple regression analyses were then conducted to determine the impact of 
covariates on the global ASSIST score, in conjunction with time (see Appendix K, Tables 
K5-K11). Dosage had a significant impact on the global ASSIST score which decreased by 
12.83 units on average when the dosage increased by 1%. The average decrease in the global 
ASSIST score of 0.03 units when the self-efficacy score increased by 1 unit was significant. 
The SOCRATES Taking Steps score had a significant effect on the global ASSIST score 
which decreased by 1.02 units on average when SOCRATES Taking Steps increased by 1 
unit. The SOCRATES Recognition score had a significant effect on the global ASSIST score 
which increased by 0.44 units on average when SOCRATES Recognition increased by 1 unit. 
Although all of these variables reflect change over time there were no significant interaction 
effects between these variables and time. As previous clean time had no impact on the global 
ASSIST score over time nor NA/AA affiliation, nor SOCRATES Ambivalence; only dosage, 
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self-efficacy, SOCRATES Taking Steps and SOCRATES Recognition were included in a 
final model for global ASSIST (together with time).  
A multiple mixed effects regression looking at the adjusted effect of each of the 
significant variables was performed (see Table 26). Findings include that Time had a 
significant impact on the global ASSIST score: The global ASSIST score decreased 
significantly by 35.41 units on average when comparing 10 weeks post-admission to 
admission and by 34.08 units on average when comparing 6 weeks post-admission to 
admission. However, between 6 weeks post-admission and 10 weeks post-admission there 
was no significant change in global ASSIST scores. 
Dosage was significant: The global ASSIST score decreased by 10.27 units on 
average when the dosage increased by 1%. Self-efficacy had a significant impact on the 
global ASSIST score which decreased by 0.02 units on average when self-efficacy increased 
by 1 unit. SOCRATES Taking Steps had a significant impact on the global ASSIST score 
which decreased by 1.28 units on average when SOCRATES Taking Steps increased by 1 
unit. Lastly, SOCRATES Recognition also had a significant impact on the global ASSIST 
score which increased by 0.79 units on average when the SOCRATES Recognition score 
increased by 1 unit. 
 
Table 26 
 
Regression Results for Non-Imputed Data Analyses (n=89): Predicting substance misuse 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 52.82 10.94 221.87 4.83 .000 31.25 74.38 
6 Weeks Post-Admission -1.33 2.22 166.83 -0.60 .551 -5.71 3.06 
10 Weeks Post-Admission 34.08 4.05 134.91 8.41 .000 26.07 42.10 
Dosage -10.27 2.84 198.81 -3.62 .000 -15.87 -4.67 
Self-Efficacy -0.02 0.01 131.86 -2.78 .006 -0.03 0.00 
SOCRATES Taking Steps -1.28 0.33 232.93 -3.86 .000 -1.94 -0.63 
SOCRATES Recognition 0.79 0.17 190.01 4.59 .000 0.45 1.12 
 
Mixed effect simple regressions were run on each variable in turn to observe independent 
changes at each of the follow-up time points of 6 weeks post-admission and 10 weeks post-
admission as displayed in Figure 4 (self-efficacy scores were divided by 10 in order to plot 
them on the same scale as other variables). AA affiliation, SOCRATES Recognition and 
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SOCRATES Ambivalence did not change significantly at any time point. Self-efficacy scores 
increased significantly from admission to 6 weeks post-admission and significantly from 
admission to 10 weeks post-admission and SOCRATES Taking Steps scores did the same. 
Scores of both these variables did not change significantly from 6 weeks post-admission to 10 
weeks post-admission (see Tables 27-31). The effects of all covariates on the global ASSIST 
score maintained the same magnitude and direction found in the analysis of the sample of 98 
participants. 
 
 
Figure 4: Average Variables Scores  
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Table 27 
Regression Results for Non-Imputed Data Analyses (n=89): Self-Efficacy vs. Time 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 486.04 12.32 88.00 39.46 .000 461.57 510.52 
6 Weeks Post-Admission 35.81 25.84 135.63 1.39 .168 -15.30 86.91 
10 Weeks Post-Admission -122.78 20.77 161.77 -5.91 .000 -163.79 -81.76 
 
Table 28 
Regression Results for Non-Imputed Data Analyses (n=89): AA Affiliation vs. Time 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 1.28 .32 88.00 4.05 .000 .65 1.91 
6 Weeks Post-Admission .21 .39 162.23 .54 .588 -.56 .99 
10 Weeks Post-Admission -.16 .37 147.85 -.42 .674 -.90 .58 
 
Table 29 
Regression Results for Non-Imputed Data Analyses (n=89): SOCRATES Recognition vs. Time 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 31.40 0.87 87.00 35.89 .000 29.66 33.14 
6 Weeks Post-Admission -0.82 1.11 164.07 -0.74 .461 -3.01 1.37 
10 Weeks Post-Admission 0.74 1.02 140.87 0.73 .468 -1.27 2.75 
 
Table 30 
Regression Results for Non-Imputed Data Analyses (n=89): SOCRATES Taking Steps vs. Time 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 37.67 0.40 87.00 94.62 .000 36.88 38.46 
6 Weeks Post-Admission 0.02 0.55 173.49 0.04 .967 -1.06 1.11 
10 Weeks Post-Admission -2.26 0.66 161.35 -3.41 .001 -3.57 -0.95 
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Table 31 
Regression Results for Non-Imputed Data Analyses (n=89): SOCRATES Ambivalence vs. Time 
 
Parameter Estimate 
Std. 
Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 84.81 1.43 87.00 59.38 .000 81.97 87.65 
6 Weeks Post-Admission -0.72 1.94 172.72 -0.37 .712 -4.54 3.11 
10 Weeks Post-Admission -1.42 1.81 163.71 -0.79 .433 -4.99 2.15 
 
 
To establish any association between global ASSIST scores at 10 weeks post-admission 
against self-efficacy scores at 6 weeks post-admission a Spearman correlation test was 
conducted. A significant negative impact was found by self-efficacy levels at 6 weeks post-
admission on the 10 week global ASSIST score (rho= -0.343, p=0.001).  
Treatment Services Assessment  
The majority of all participants strongly agreed with all statements put to them from the 
Treatment Services Assessment Questionnaire (see Table 32). The most mixed response was 
to question 6 relating to HIV risk-reduction with 56.12% of participants strongly agreeing 
and 10.2% disagreeing with the statement. Question 1 regarding waiting-time for services had 
relatively fewer responses in the Strongly Agree category (67.35%) as did question 4 
concerning adequate time spent with participants by Centre staff (71.43%). The highest 
number of responses in the Strongly Agree category was to question 7, which pertains to 
recommendation of the Centre to others, at 85.71%. Respondent levels in the Disagree 
category were generally low (below 7% - bar Question 6) as were levels in the Somewhat 
Agree categories for all questions.   
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Table 32 
Response to Treatment Services Assessment (n=98)  
         
  
Question 
Number 
  
Question 
N/A Disagree Somewhat 
Agree 
Agree Strongly 
Agree 
Missing 
Mean (Std Dev.) 
  N (%) N (%) N (%) N (%) N (%) N (%) 
1 The amount of time I had to wait to 
get services was acceptable to me. 
1 (1.02) 1 (1.02) 2 (2.04) 27 (27.55) 66 (67.35) 1 (1.02) 3.61 (0.05) 
2 The staff treated me with respect. 1 (1.02) 0 (0) 1 (1.02) 17 (17.35) 78 (79.59) 1 (1.02) 3.76 (0.04) 
3 The staff were sensitive to my 
background. 
1 (1.02) 2 (2.04) 1 (1.02) 16 (16.33) 77 (78.57) 1 (1.02) 3.71 (0.05) 
4 The staff spent enough time with 
me. 
1 (1.02) 3 (3.06) 2 (2.04) 21 (21.43) 70 (71.43) 1 (1.02) 3.61 (0.06) 
5 I had access to all the services I 
needed for my recovery. 
1 (1.02) 6 (6.12) 3 (3.06) 14 (14.29) 73 (74.49) 1 (1.02) 3.57 (0.06) 
6 This Centre helped me reduce my 
HIV Risk. 
3 (3.06) 10 (10.2) 6 (6.12) 23 (23.47) 55 (56.12) 1 (1.02) 3.21 (0.08) 
7 I would recommend this service to 
others. 
1 (1.02) 4 (4.08) 1 (1.02) 7 (7.14) 84 (85.71) 1 (1.02) 3.74 (0.05) 
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Responses to Question 8 (see Table 32) asking for programme improvement suggestions 
were extremely positive with 79.53% of participants expressing satisfaction with the 
programme as it is. The most frequent suggestion was to extend the time of individual 
counselling sessions or to make more of them available (7.14%). In a similar vein, 4.08% of 
participants suggested that the programme length be extended. The same amount wanted the 
format of group sessions to be addressed, e.g. to ask each person in turn for input, and 3.06% 
suggested the employment of addicts in recovery as counsellors. 
 
Table 33 
Answers to Question 8 by Percentage: How in your opinion could this programme be improved? 
  Response  (%) 
No improvement necessary with unsolicited praise for the entire      
programme (wonderful, excellent, superb, good )                   68.31 
No improvement necessary 11.22 
Would like to see more advertising or marketing of the Centre 7.14 
Would like more time in individual sessions or more individual sessions 
available 7.14 
Would like more outlets in more locations 6.12 
Would like the programme length to be extended 4.08 
Would like attention to be paid to the format of group sessions 4.08 
Would like some addicts in recovery as counsellors at the Centre 3.06 
Would like more sensitivity in reception staff 1.02 
Would like sensitivity levels of counsellors to be addressed 1.02 
Note. Comments not relating to the improvement of the programme itself but 
were general suggestions (e.g. Marketing, advertising, more locations) were 
listed in this table as well as recorded as a ‘no improvement necessary’ 
response). 
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 CHAPTER SIX 
Discussion 
Baseline Characteristics 
Substances of choice. 
Popular drug choices of participants followed established treatment admission trends, with 
methamphetamine use of 39%  in the High-Risk category far exceeding use of any other drug 
in the In-Treatment category: Western Cape treatment intake statistics reflect an average of 
37% of clients who reported methamphetamine as their primary drug of choice during 2011 
(Dada et al., 2011). Heroin use at High-Risk (34%) in the Assessment-Only category far 
exceeded that of the next most used drug, methamphetamine, at 23%. No literature relating to 
this scenario was found, but in general, in-treatment retention rates for heroin are notoriously 
low. Davoli, Perucci, Pasqualini and Bargagli (1998) report retention rates for heroin users in 
a drug-free programme of 15% at one year follow-up while another study found that  most of 
the 60% of heroin users who relapsed in their study did so soon after treatment (Gosssop, 
Stewart, Browne, & Marsden, 2002).  
Poly-substance use at admission was high with 35% of participants using two or more 
substances in the Medium-Risk category and 18% using two or more substances in High-Risk 
categories. Again these figures reflect a Western Cape trend displaying high levels of poly-
substance use with 43% of patients on intake reporting abuse of more than one substance in 
2010 (Plüddemann et al., 2010). 
Demographics. 
An overview of baseline characteristics of In-Treatment and Assessment-Only groups yielded 
interesting results: Low representation of Black participants compared to Coloured and White 
participants reflected a similar trend to treatment intake demographics of the Centre. A study 
based on a national survey of 15, 846 participants found a significant difference between 
White and Coloured males’ actual illicit drugs usage compared to Black males, with White 
and Coloured males both more than twice as likely to use as their Black counterparts (Njuho 
& Davids, 2010). Trends in admissions across the country in 2011 reflect a lower proportion 
of Black/African patients in treatment than would be expected by underlying demographics 
(Dada et al., 2012), while another study found a very low prevalence of hazardous use of 
substances among Black women (Ward et al., 2008). However, even taking these factors into 
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account, Black clients are under-represented at this centre. This is in line with Myers and 
Parry’s (2005) findings which reflect an under-utilization of clinical treatment services by 
Black South Africans. That study lists barriers to treatment as, lack of treatment personnel 
with similar cultural and language backgrounds; the stigma associated with seeking 
treatment; and service and transportation costs. However, the comparatively high rates of 
retention in treatment of Black clients (20%) compared to other population groups in our 
study (Coloured; 32%: White; 24%) may be indicative of focused efforts by the Centre to 
accommodate Black South Africans: Black, Xhosa-speaking applicants for jobs at the Centre 
are strongly favoured with one Black, Xhosa-speaking counsellor currently employed at the 
Centre. This counsellor and another Black, Xhosa-speaking counsellor from the Mitchell’s 
Plain location are currently undertaking a community survey and an awareness initiative in 
historically Black, Xhosa-speaking communities.  
As the literature indicates that treatment retention rates are similar for men and 
women (Hser, Evans, & Huang, 2005; Greenfield et al., 2007) the lower proportional loss of 
women (18%) to men (31%) after assessment may also be suggestive of the success of 
measures already taken at the centre reflecting particular sensitivity towards women: Women 
clients are referred to a female therapist unless a male therapist is specifically requested 
(change to a female therapist is permitted at any stage); a specific women’s programme is 
offered, in particular an exclusive women’s group, which includes only women clients and 
only women counsellors as facilitators; and pregnant women receive priority service at intake 
- i.e., pregnant women are accommodated at the next intake regardless of current bookings. It 
may also be possible that the counselling style of MI holds a particular appeal for women, as 
a United Nations report (2004) relating to substance abuse treatment for women specifically 
advocates for implementation of a programme which includes motivational enhancement 
counselling.   
Gender distribution was uneven with 3 males for every female in the In-Treatment 
group. These figures are indicative of gender admission trends at the centre and reflect 
findings of a study investigating correlates of substance use which show a higher prevalence 
for substance use in men (Ward et al., 2008). In addition, the lower numbers of women 
admitted in our study are in keeping with findings of a study investigating gender differences 
in barriers to substance use treatment (Myers, Louw, & Pasche, 2011). These include that 
women share a core set of predictors with their male counterparts in relation to barriers to 
treatment utilization but are more vulnerable to barrier effects and therefore less likely to seek 
treatment. Both genders, for example, consider financial accessibility a barrier to treatment, 
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but women are more cognizant of other competing financial needs. Although there is no 
special rate at the Centre for women, all clients have the option of applying for a fee discount 
or free service by completing a financial assessment form. The same study identified a 
stronger association in women than men of treatment facilities awareness with treatment 
utilization (Myers et al., 2007), so a suggestion for target interventions emanating from that 
study’s findings could possibly be to use community-based outreach workers to increase 
women’s awareness, in particular, of the Centre. 
Summary of Findings 
Analyses performed on the sample of all 142 In-Treatment clients with inserted baseline data 
replacing missing data reflected a significant reduction in substance use and substance 
dependence. It was found that dosage, self-efficacy, SOCRATES Taking Steps and 
SOCRATES Ambivalence were significantly associated with global ASSIST scores in a 
negative direction, meaning that substance dependence decreased when these variables’ 
scores increased. SOCRATES Recognition scores were significantly positively associated 
with substance dependence which increased when SOCRATES Recognition levels decreased. 
These findings were generally in line with those of tests run on data collected at two time 
points, without imputed data, for the 98 participants who both received the programme and 
who were contacted at follow-up. This alignment in findings suggests that there are positive 
outcomes for participants who choose to be exposed to the treatment programme as the 
association is so strong that even ‘diluted’ by inserted baseline data it remains significant. 
The only exceptions were that SOCRATES Ambivalence was significantly negatively 
associated with global ASSIST scores in the inserted baseline data sample but not in the 98 
participant two time-point group. The fact that dosage was significantly negatively associated 
with global ASSIST scores in both the 142 and 89 participant groups, and approached 
significance in the 98 participant group, was particularly encouraging.  
Analyses of the three time-point follow-up sample (n=89) revealed similar results to 
that of the larger (n=98) sample in that in both, the effects of all covariates on the global 
ASSIST score maintained the same magnitude and direction. Differences in variable scores at 
significant levels between the time points of 6 weeks post-admission and 10 weeks post-
admission were found in self-efficacy scores as well as in global ASSIST scores. Substance 
dependence dropped significantly at 6 weeks post-admission and that decrease was 
maintained at the 10-week post admission follow-up, indicating both that participants reduced 
substance dependence soon after admission into the programme and maintained that 
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reduction through to at least 10 weeks post-admission. The significant negative association of 
self-efficacy scores at 6 weeks after admission with substance use levels at 10 weeks post-
admission was an extremely relevant finding from a possible treatment tool perspective. As 
the results of all three analysed groups followed the same trend, and, as the feasibility of 
generalizing the two time-point group’s (n=98) results to the remainder of the sample has 
already been established, only the results of this group (n=98) are addressed in any depth in 
this discussion.  
The 46% complete abstinence and significant reduction of substance use together with 
significant increases in self-efficacy and SOCRATES Taking Steps from admission to 10 
weeks post-admission were encouraging. So too were the results of the adjusted effects 
regression indicating that these same variables were significantly and positively associated 
with reduced substance dependence scores. Also encouraging was the association of dosage 
on substance dependence, which approached significance at 0.72%. This relationship, 
especially in the context of dosage’s significant association with substance dependence levels 
in the other two analyses performed, offers tentative evidence of a positive association 
between amount of exposure to the treatment programme and levels of substance dependence 
and tentatively suggests that it is possible that it is the programme that is making the 
difference in clients’ substance dependence levels. The SOCRATES Taking Steps association 
with reduced substance levels was also a finding of particular interest in terms of that 
measure’s possible future use as a treatment tool to predict successful change in clients’ 
substance use.  
Outcomes 
Substance use. 
No other treatment outcome study relating to our study’s follow-up intervals, treatment 
components, counselling style and length of treatment programme in an out-patient context 
was found with which to directly compare these results. However, meta-analytic data 
resulting from investigations of the efficacy of motivational interviewing, and analysed by 
Burke et al. (2003), gives some idea of expectations of substance use outcomes relating to 
motivational enhancement interviewing techniques. Although abstinence is the most stringent 
criterion for treatment outcome (Gossop et al., 2002), abstinence and noticeable improvement 
in substance use were frequently conflated categorically across the seven studies incorporated 
in that meta-analysis, and included follow-ups from four weeks to four years post-treatment 
in a (Burke at al., 2003). Our study’s results of 47% abstinence, 13% once or twice alcohol 
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use over the follow-up period, and significant reduction of substance use of the remainder of 
the participants, compared extremely favourably to Burke and colleague’s findings that 54% 
of participants receiving stand-alone adapted motivational interviewing interventions 
experienced overall improvement in alcohol and drug use. Even the remaining 53% of 
participants in our study, who did not report abstinence at the 10-week follow-up period, had 
significantly reduced their substance use, offering further evidence of outcomes favourably 
comparable to Burke and colleagues’ (2003) findings. 
All participants stopped using heroin on a daily or almost daily basis, and the 89% 
proportion of participants who abstained completely from heroin is an excellent outcome and 
an indication of the effectiveness of the programme. However, it is practical to exercise 
caution before extrapolating these results to long-term expectations as the literature reveals 
high rates of relapse over time in relation to this drug. One study found that, post-treatment, 
abstinence from heroin was consistently significantly lower at up to 1 year follow-up than for 
any other drug. However, more than half of heroin users who relapsed after residential 
treatment did so within the first three days after discharge and 75% within one week (Gossop, 
Stewart, Browne, & Marsden, 2002). Our study’s last follow-up time-point was at least four 
weeks after completion of treatment so the outcome results of this centre considerably exceed 
those of Gossop and colleagues’ (2002) study. A United States national treatment outcome 
research study, which included residential programmes, found that 28.6% of its participants 
were abstinent at the 1-year mark (Gossop, Marsden, Stewart, & Kidd, 2003).  
 Methamphetamine-related abstinence was good with a 73% abstinence rate at 10 
weeks post-admission: Daily or Almost Daily use reduced by 88% and weekly use by 75%. 
Participants using methamphetamines on an irregular basis appear to have continued to do so 
with only a 10% change reflected in the Once/Twice category. These results compare 
favourably with outcomes of participants in an intensive 16 week out-patient programme, 
where findings include that 58.8% of methamphetamine users used both drugs and alcohol 
during treatment (Rawson, Gonzales, Obert, McCann, & Brethren, 2005). Our findings, 
therefore, reflect well on the Centre in that this achievement easily falls within abstinence 
rates achieved by out-patient programmes elsewhere. Considering the prevailing concerns 
relating to methamphetamine use and its social and health implications discussed earlier, 
these results are particularly encouraging.  
High abstinence levels were also reported for cocaine with an improvement of 84% in 
abstinence and sedatives with an 85% increase in abstinence. Interestingly, alcohol use in the 
Once or Twice category actually increased by 50%, although there were substantial declines 
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in use in the Daily/Almost Daily (78%) and Weekly (50%) categories for alcohol. It seems 
logical to assume that some participants replaced their illicit drug-of-choice with alcohol on 
occasion. However much this reduced drinking pattern may be considered to fall within 
socially normative parameters - the guideline for “moderate” drinking limits by the United 
States National Institute on Alcoholism and Alcohol Abuse is ≤1 standard drink per day for 
adult women and for anyone over age 65, and ≤2 standard drinks per day for adult men 
(Whitlock et al., 2004) - the substance use and abuse history of participants flags this as a 
matter of concern. Also, longer-term follow-up would be necessary to reveal whether this 
pattern of drinking was sustained. This drinking behaviour seems analogous to drug 
substitution, a practice advocated in some harm reduction therapies, where more harmful 
substances are replaced with either other perceived less harmful substitutes which may be 
considered acceptable or more moderate use of the drug of choice (Reiman, 2009).  
Dosage. 
The significant association of programme dose with the global ASSIST score both in the 
group of 89 participants who were interviewed at all three time points and in the full in-
treatment sample of 142 participants, makes the finding of the association of dosage with the 
global ASSIST score approaching significance in the group of 98 participants particularly 
encouraging. This tentatively suggests that the more exposure clients have to the treatment 
programme, the more their substance dependence is reduced. An average period of time in an 
out-patient drug treatment programme is recommended to be of no less than 6 months with a 
minimum of attendance of three sessions per week (Simpson et al., 1997). As this is 
consistent with findings that more time in treatment is associated with better outcomes 
(Simpson et al 1997) and that a significant positive relationship between higher treatment 
doses and better study outcomes exists (Burke et al. 2003), it is important that the Centre  
continues to focus on retention of clients in the programme. 
Self-efficacy.  
The significant increase of self-efficacy scores from admission to 10 weeks post-admission 
and the significant association of self-efficacy scores over time with the reduction of global 
ASSIST scores imply successful application of programme theory by Centre staff. The 
significant association found by self-efficacy levels at 6 weeks post- admission with 10 week 
post-admission substance use scores (Question 2) support findings of Goldbeck, Myatt and 
Aitchison (1997) that end of treatment efficacy levels are predictive of reduced substance use 
levels at 12-week follow-up (marginally longer than in this study). Similarly, these results 
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support findings that higher levels of abstinence self-efficacy are associated with better short-
term substance abuse outcomes, while lower levels are linked to higher risks of short-term 
relapse (Moos & Moos, 2007) and higher levels of self-efficacy are associated with less 
frequent substance use at both 1 and 6 months follow-up after end-of-treatment (Morgenstern 
et al., 1997). In a sample of 2, 967 substance abusing males, high self-efficacy levels at end-
of-treatment were the strongest predictor of abstinence at 1-year post treatment with 100% 
self-efficacy showing the greatest association with abstinence for the same time period (Ilgen, 
McKellar, & Tiet, 2005). These authors comment on the usefulness of assessing self-efficacy 
levels in order to identify participants who will be less or more likely to experience positive 
outcomes after treatment, underscoring the possible utility of this questionnaire as a tool to 
assess the need for clients to participate in the Centre’s aftercare programme.  
SOCRATES sub-scales. 
Recognition. 
Levels of SOCRATES Recognition are not expected to increase over time as these levels are 
positively associated with problem severity and problem severity is expected to decrease. 
Therefore the significant positive relationship between SOCRATES Recognition scores and 
global ASSIST scores is in keeping with Miller and Tonigan’s (1996) assertions that higher 
levels of recognition of a drinking or drugging problem imply greater problem severity. This 
relationship remained stable over time, indicating that the Recognition sub-scale could be a 
useful additional treatment tool for counsellors to determine problem severity, as well as to 
address clients’ levels of recognition of their problem. 
Taking Steps. 
The fact that the Taking Steps score increased significantly between admission and 10 weeks 
after admission tentatively implies again the successful application of programme theory as 
levels of this sub-scale of motivational levels increased in clients. The significant inverted 
relationship between SOCRATES Taking Steps and reduced drinking or drugging over time 
is also in keeping with Miller and Tonigan’s (1996) findings that high Taking Steps scores 
are predictive of successful change and this again offers counsellors the opportunity to gauge 
motivation levels of clients before and during their treatment process to assess progress.  
Ambivalence. 
The intention of the SOCRATES motivation for change assessment is to be of practical use in 
a clinical setting as well as in a research context and could reflect the impact of the 
intervention in all three of the SOCRATES sub-scales (Miller & Tonigan, 1996). These 
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authors make no predictive claims relating to their Ambivalence measurement and advise 
only that Ambivalence scores indicate levels of openness to reflection. Ambivalence is 
regarded as a core concept in the treatment programme at the Centre, being as it is a core 
concept of MI, and regarded as the primary barrier to change in a substance use context 
(Cloud, 2006). The MI counselling style focuses on resolving ambivalence which, therefore, 
makes the standardized measurement of this construct a useful tool for Centre staff to assess 
the levels of ambivalence presenting in their clients at admission and at any stage throughout 
the treatment programme. In keeping with claims of Cloud et al. (2006), these levels should 
change as ambivalence is resolved. However, another possible explanation postulated by 
programme theory and supported by Cloud et al. (2006) is that ambivalence is a constantly 
fluctuating state and consequently is not expected to follow a linear path to resolution. Other 
explanations for this lack of significant change could pertain to the ambiguity of the 
ambivalence-related questions acknowledged by Miller and Tonigan (1996) and the 
possibility that the en masse restructure of the ambivalence variable did not accurately reflect 
levels of ambivalence.  
Previous clean time. 
The negative association between previous clean time at admission and the 10 week post-
admission global ASSIST score marginally above the 5% level of significance tentatively 
suggests that the Centre staffs’ hypothesis was well-founded. There was a dearth of literature 
on the association of previous clean time and treatment outcomes. However, it does make 
intuitive sense that longer clean time should be predictive of treatment success. Centre staff 
expressed their expectations of this association based on observations of successful outcomes 
of clients in treatment with previous clean time. Some insight into previous clean time and its 
relationship with reduced substance use or abstinence can be inferred by studies relating to 
relapse:  A comprehensive study into the trajectory of recovery for participants abusing 
cocaine reports the path of a cocaine abuser as a sequence of transitions. These transitions 
may include establishing abstinence, lapse and relapse or any permutation of these. In that 
study, 81% of participants (not on the incentive programme) relapsed and 17% re-established 
abstinence but only after either relapsing or experiencing a lapse (Milby et al., 2004). 
Conversely then, those substance users who successfully eventually established abstinence in 
that study, had experienced periods of clean time before. This offers some support to Centre 
staffs’ theory that clients are more likely to have successful substance use outcomes after 
experiencing previous clean time. 
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NA/AA affiliation. 
Our findings of no significant change of NA/AA affiliation over all time points, and no 
significant effect of NA/AA affiliation scores on the global ASSIST scores, raises some 
questions. The most important of these is why were clients so laggardly in attending meetings 
and pursuing affiliations with AA/NA both during and after treatment? A review of the 
literature by Cloud et al. (2006), relating to 12-Step compliance after treatment, indicates that 
most subjects drop out of, or sporadically attend 12-Step programmes after end-of-treatment. 
In the light of all the positive associations found in the literature between NA/AA affiliation 
and; sustained motivation (Morgenstern, Labouvie, Mcrady, Kahler, & Frey, 1997); increased 
self-efficacy, changes in social network support and improvement in substance abuse 
problems (Laffay, McKellar, Ilgen, & Moos, 2008); extreme attitude changes (Cook, 1988); 
and good recovery outcomes (Piedmont, 2004), further investigation into possible reasons for 
this lack of change seemed warranted.  
A study comparing the efficacy of a directional approach against a motivational 
interviewing approach to facilitating involvement in AA in the context of a skills-building 
treatment programme, yielded results possibly pertinent to our study. Findings include that 
exposure to the directional approach resulted in more active involvement with AA and more 
days of abstinence at the 12 month follow-up than in participants exposed to the motivational 
enhancement approach. The motivational enhancement approach had no impact on AA-
related variables. Possible reasons cited were that there was less direct exposure to AA-
related concepts in the motivational enhancement condition, compared to the directional 
approach, and the percentage of AA-related material offered in the directional condition was 
almost twice as much as that offered in the motivational enhancement approach. The 
directional counselling condition was also more successful than the treatment-as-usual 
condition in maintaining AA attendance, and participants in the directional approach 
condition reported more days abstinent than the treatment-as-usual group (Walitzer, Dermen, 
& Barrick, 2008). Another study compared outcomes of patients from ‘intensive referral’ and 
‘standard referral’ treatment conditions (Timko et al., 2006). In the first condition both client 
and counsellor were actively involved in initiating contact with 12-Step self-help groups, 
which included arranging to attend meetings, arranging initial sponsors and working through 
a journal kept by clients of concerns and experiences within the group. This was in addition 
to receiving support offered under standard referral conditions, which included descriptions 
of self-help meetings, schedules of self-help meetings, and encouragement to attend 12-Step 
self-help meetings. The intensive referral group reported significantly more 12-Step 
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involvement and more improvement in alcohol and drug use at 6 months after treatment than 
the standard referral group. 
Considering that NA/AA meetings are free of charge (apart from voluntary 
contributions) and the target populations of the Centre are those living in low socio-economic 
areas with limited financial capacity, it is extremely important that clients be introduced to 
the benefits of NA/AA affiliation before end of treatment. Read et al. (2001) advise referring 
clients to 12-Step programmes as part of a substance abuse treatment programme for the 
combined reasons of affordability and effectiveness, while Humphreys & Moos (2007) 
suggest that attending 12-Step self-help groups not only improves post-treatment outcomes 
but reduces the cost of continuing care to government.  
Based on interim findings of this report, the Centre has already instituted procedures relating 
to following up clients’ attendance at NA /AA, and plans are well underway for the Centre to 
host NA/AA meetings on its premises. Attendance of these meetings will be compulsory and 
incorporated as another treatment component into the programme. These NA/AA meetings 
may strengthen both the likelihood of achieving abstinence, but particularly the likelihood of 
clients’ maintaining that abstinence and should address issues around the reduction of levels 
of abstinence in the Alcohol category.  
Treatment services assessment. 
The overwhelmingly positive responses to the Treatment Services Assessment questionnaire 
were indicative of clients’ personal satisfaction at levels of service received in all categories 
addressed. The majority of all participants strongly agreed with all statements put to them. 
Disagree responses from clients relating to not having enough time spent with them were in 
fact positive from the perspective that respondents generally wanted the programme 
expanded to incorporate more or longer individual sessions. The highest number of responses 
in the Strongly Agree category was to Question 7, which pertains to recommendation of the 
Centre to others (85.71%), while respondent levels in the Disagree category were generally 
low (below 7%). The mixed response relating to the HIV risk-reduction questionnaire may 
have been due to embarrassment at perceived admission of promiscuity to the interviewer. 
Suggestions for improvement were generally related to marketing issues and not programme 
problems per se. Eighty percent of participants interviewed felt that the programme works 
well as it is and that no improvement was necessary. 
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Limitations 
This was not an experimental study, i.e. no equivalent randomized control group without 
exposure to treatment was used. As causal relations cannot be firmly inferred by data from a 
non-experimental study, our findings remain tentative. However, as almost all findings were 
in line with both programme and social science theory, it is likely that the programme was 
responsible for the changes found.  
 These findings are limited to the Cape Town Drug Counselling Centre Adult 
Treatment Programme and therefore are not generalizable to any other treatment population. 
The short duration of follow-up is also a limitation of this study as it is possible that findings 
may have differed after a longer period of time had elapsed. 
Due to budgetary constraints preventing toxicological screenings as confirmation of 
participants’ claims of abstention, reliance on self-report from participants was a necessity. 
Simpson (1993) mentions a methodological vulnerability of the longitudinal Drug Abuse 
Reporting Programme established in the 1970’s as use of self-report data from unreliable 
sources, namely drug addicts. This is a problem raised in other studies as a methodological 
limitation (Bodin et al.,2006; Winters et al., 2000). However, Del Boca & Brown (1996) 
found that in the context of addicts’ or alcoholics’ reputed unreliability and questionable 
credibility, considerations of, for example, the participants’ level of sobriety should enable 
the interviewer to structure the assessment pr cess to maximize reliability and validity of the 
instruments of measurement. Confirmatory evidence of respondent reliability was found in a 
large sample of US Project MATCH, where participants’ self-reported drug use was highly 
consistent with the results of urine drug screens. In addition it was found that discrepancies 
were often due to negative screening results which contradicted participants reported drug or 
alcohol use rather than the reverse (Project MATCH Research Group, 1997a). Although only 
self-report data was used, the measuring instruments utilized in this study were standardized 
and have already demonstrated validity and reliability in other studies, as well as being 
widely used in the field of substance use. 
Despite these limitations this study provides evidence of significant positive 
outcomes, both in the reduction of substance use and substance dependence, and in the 
significant change of motivational levels and self-efficacy in expected directions. Of 
particular interest too, is evidence of support of programme and social science theory, which 
postulates relationships between levels of different psychological variables and substance use 
outcomes. 
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Recommendations 
Outcomes of this Centre’s programme were good in most of the areas under evaluation. The 
programme appears to be having an effect and suggestions put forward are offered only to 
possibly strengthen the existing programme. Based on this study’s interim findings, low 
levels of involvement in NA/AA affiliation have already been constructively addressed by the 
Centre, as detailed above.   
The Centre may find measures of recognition of problem severity and taking steps 
towards change useful treatment tools. However, the SOCRATES measurement of 
ambivalence should only be used to individually assess clients and is not recommended for 
any contribution towards composite scores of multiple clients. The Drug Confidence 
questionnaire measuring levels of self-efficacy may be of considerable use to the Centre in 
assessing the potential of clients to maintain their outcomes success after treatment, and 
consequently, the appropriateness of encouraging their participation in after-care treatment. 
These tools may also be useful clinically, by identifying areas that may need additional input.  
In keeping with the advice of Myers and colleagues (2007), community-based 
outreach programmes already put in place by the Centre could be augmented with the aim of 
particularly increasing women’s awareness of treatment options available to them. 
Although the Centre uses a substance use feedback form to raise discrepancy in 
clients presenting for treatment, this consists of questions developed by the Centre for this 
purpose. A standardized measuring instrument such as the ASSIST questionnaire, used in this 
study, may be of additional therapeutic benefit. This questionnaire incorporates a broad range 
of drugs listed separately to comprehensively gauge levels of poly-substance use, which 
could optimize the opportunity for counsellors to raise discrepancy in their clients by 
illustrating to them the prevalence and consequences of their behaviour.  
Conclusion 
The data indicate significant changes in participants’ self-report over time, and these changes 
suggest that the programme’s work has been valuable. Individual substance use reduction 
was high and the 47% abstinence achieved, in combination with the significant reduction of 
substance use of the remaining participants, compared extremely favourably with outcomes 
of other motivational interviewing outcomes studies. It can be tentatively suggested then that 
there appears to be a treatment programme effect, which is illustrated by the combination of 
successful and reduced substance use outcomes, and severity of dependence, positively 
linked to the amount of exposure to treatment. In addition, the expected changes, predicted by 
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programme and social science theory, in elements of the causal chain mechanism, namely 
self-efficacy and levels of motivation, and their associations with reduction in substance use 
and substance dependence offer further evidence of programme efficacy. Although NA/AA 
affiliation did not increase as expected this shortcoming made us more confident that changes 
found were due to the treatment programme and not any other competing recovery 
mechanism. All of these programme effects are particularly encouraging in the context of the 
relative cost-effectiveness and short duration of the treatment programme as well as the high 
levels of satisfaction of participants with the treatment programme. 
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Appendix A  
Alcoholics Anonymous Affiliation Questionnaire 
 
NA/AA Affiliation: 
 
Please Answer Yes or No /Antwood asb Ja of Nee 
 
 
 
1 Have you ever considered yourself a member of NA/AA?   
   Het u ooit uself beskou as 'n lid van NA/AA?   
 
2 Have you ever called an NA/AA member for help? 
   Het u ooit 'n NA/AA lid geskakel vir hulp? 
 
3 Do you now have an NA/AA sponsor?  
Het u tans 'n NA/AA Borg? 
 
4 Have you ever sponsored anyone in the NA/AA?   
   Het u al ooit iemand geborg in die NA/AA? 
 
5 Have you ever had a spiritual awakening or conversion  
    experience through your involvement with NA/AA? 
Het u al ooit 'n geestelike ontwaking of sukses ervaar  
   deur middle van u betrokkenheid by NA/AA? 
 
6  In the past 12 months, have you read NA/AA literature?   
    Het u enige literatuur van die NA/AA gelees gedurende 
    die laaste 12 maande? 
 
7 In the past 12 months have you done service, helped 
   newcomers, or set up chairs, made coffee, cleaned up  
   after a meeting etc?   
Het u diens gedoen, gehelp met nuwelinge, stoele  
  uitgesit, koffie gemaak, skoongemaak na 'n  
  byeenkoms die laaste 12 maande? 
 
8 How many NA/AA meetings would you estimate that you 
   have gone to during the past 3 months?  
Volgens u berekeninge hoeveel NA/AA byeenkomste  
   het u bygewoon die laaste 3 maande? 
 
9 How many NA/AA meetings have you gone to in the last 12 months? 
   Hoeveel NA/AA byeenkomste het u bygewoon die laaste 12 maande? 
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Appendix B 
Alcohol, Smoking and Substance Involvement Screening Test (WHO ASSIST V3.0) Questionnaire 
 
ALCOHOL, SMOKING AND SUBSTANCE INVOLVEMENT SCREENING TEST ALKOHOL, 
ROOK EN DWELM MIDDEL BETROKKENHEID SIFTINGSTOETS 
Question 1 
 
In your life, which of the following substances have you ever used? (Non-
medical use only)  
 
Watter van die volgende dwelm middels het jy al ooit gebruik? (Nie-
mediese gebruik alleenlik) 
 
 
 
No/Nee 
 
Yes/Ja 
a. Tobacco products (cigarettes, chewing tobacco, cigars etc.)    
Tabak produkte (sigarette, kougom tabak, sigare ens) 
 
0 3 
b. Alcoholic beverages (beer, wine, spirits etc.)  
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 3 
c. Cannabis (marijuana, dagga, grass etc.)  
Cannabis (marijuana, dagga, ens) 
 
0 3 
d. Cocaine (coke, crack etc.)  
Kokaine (coke, crack ens) 
 
0 3 
e. Amphetamine -type stimulants (tik, speed, diet pills, ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet pille, ecstasy ens) 
 
0 3 
f. Inhalants (nitrous, glue, petrol, paint thinners etc.)   
Inasemingsdwelm (nitrous, gom petrol, verfverdunner ens) 
 
0 3 
g. Sedatives or sleeping pills (Valium, Serepax, Rohypnol etc.) 
Kalmeermiddels of slaappille (Valium, Serepax, Rohypnol, etc.) 
 
0 3 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special K etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, Special K, etc.) 
 
0 3 
i. Opioids (heroin, morphine, methadone, codeine etc) 
Opioids ( Heroïen, morfien, methadone, codeine ens) 
 
0 3 
j. Other- specify –  
Ander – spesifiseer- 
 
0 3 
k. Mandrax (Buttons, Whitepipe) 
 
0 3 
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Appendix B 
Question 2 
 
In the past three months, how often have you used the 
substance you mentioned (First drug, Second drug etc)?  
 
 In die afgelope drie maande, hoe dikwels het jy gebruik 
gemaak van die dwelm middles wat u genoem het (eerste 
dwelm, tweede dwelm ens) 
 
N
ev
er
/ N
oo
it
 
O
nc
e 
or
 T
w
ic
e 
/E
en
 o
f 
tw
ee
 k
ee
r 
M
on
th
ly
 
/M
a
a
nd
el
ik
s 
W
ee
kl
y/
 W
ee
k
sl
ik
s 
D
ai
ly
 o
r 
A
lm
os
t 
D
ai
ly
/ D
a
a
gl
ik
s 
of
 
a
m
p
er
 d
a
a
g
lik
s 
a. Tobacco products (cigarettes, chewing tobacco, cigars 
etc.) 
Tabak produkte (sigarette, kougom tabak, sigare 
ens) 
0 3 4 5 6 
b. Alcoholic beverages (beer, wine, spirits etc.) 
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 3 4 5 6 
c. Cannabis (marijuana, dagga, grass etc.) 
Cannabis (marijuana, dagga, ens) 
 
0 3 4 5 6 
d. Cocaine (coke, crack etc.) 
Kokaine (coke, crack ens) 
 
0 3 4 5 6 
e. Amphetamine type stimulants (tik, speed, diet pills, 
ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet pille, 
ecstasy ens) 
 
0 3 4 5 6 
f. Inhalants (nitrous, glue, petrol, paint thinners etc.) 
Inasemingsdwelm (nitrous, gom petrol, 
verfverdunner ens) 
 
0 3 4 5 6 
g. Sedatives or sleeping pills (Valium, Serepax, Rohypnol 
etc.) 
Kalmeermiddels of slaappille (Valium, Serepax, 
Rohypnol, etc.) 
 
0 3 4 5 6 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special K 
etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, Special 
K, etc.) 
 
0 3 4 5 6 
i. Opioids (heroin, morphine, methadone, codeine etc.) 
Opioids ( Heroïen, morfien, methadone, codeine 
ens) 
 
0 3 4 5 6 
j. Other- specify 
Ander – spesifiseer- 
 
0 3 4 5 6 
k. Mandrax (Buttons, Whitepipe) 0 3 4 5 6 
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Appendix B 
Question 3 
 
In the past three months, how often have you had a strong 
desire or urge to use First drug, Second drug etc)?   
 
In die afgelope 3 maande, hoe dikwels het jy 'n sterk 
begeerde of behoefte gehad om die eerste dwelm, tweede 
dwelm te gebruik? 
 
N
ev
er
 / 
N
oo
it
 
O
nc
e 
or
 T
w
ic
e 
E
en
 
of
 t
w
ee
 k
ee
r 
M
on
th
ly
 / 
M
a
a
nd
el
ik
s 
W
ee
kl
y 
/ 
W
ee
k
sl
ik
s 
D
ai
ly
 o
r 
A
lm
os
t 
D
ai
ly
 / 
D
a
a
g
lik
so
f 
a
m
p
er
 d
a
a
g
lik
s 
a. Tobacco products (cigarettes, chewing tobacco, cigars 
etc.) 
Tabak produkte (sigarette, kougom tabak, sigare 
ens) 
 
0 3 4 5 6 
b. Alcoholic beverages (beer, wine, spirits etc.) 
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 3 4 5 6 
c. Cannabis (marijuana, dagga, grass etc.) 
Cannabis (marijuana, dagga, ens) 
 
0 3 4 5 6 
d. Cocaine (coke, crack etc.) 
Kokaine (coke, crack ens) 
 
0 3 4 5 6 
e. Amphetamine type stimulants (tik, speed, diet pills, 
ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet pille, 
ecstasy ens) 
 
0 3 4 5 6 
f. Inhalants (nitrous, glue, petrol, paint thinners etc.) 
Inasemingsdwelm (nitrous, gom petrol, 
verfverdunner ens) 
 
0 3 4 5 6 
g. Sedatives or sleeping pills (Valium, Serepax, Rohypnol 
etc.) 
Kalmeermiddels of slaappille (Valium, Serepax, 
Rohypnol, etc.) 
 
0 3 4 5 6 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special K 
etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, Special 
K, etc.) 
 
0 3 4 5 6 
i. Opioids (heroin, morphine, methadone, codeine etc.) 
Opioids ( Heroïen, morfien, methadone, codeine 
ens) 
 
0 3 4 5 6 
j. Other- specify 
Ander – spesifiseer- 
 
0 3 4 5 6 
k. Mandrax (Buttons, Whitepipe) 0 3 4 5 6 
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Appendix B 
Question 4 
 
In the past three months, how often has your use of 
(First drug, Second drug etc) led to health, social, legal or 
financial problems?  
 
In die afgelope drie maande, hoe dikwels het jou 
gebruik van (Eerste dwelms, Tweede dwelms ens) gelei 
tot gesondheidsorg, sosiale, wetlike of finansiële 
probleme? 
 
N
ev
er
/ N
oo
it
 
O
nc
e 
or
 T
w
ic
e 
/E
en
 o
f 
tw
ee
 k
ee
r 
M
on
th
ly
/ 
M
a
a
nd
el
ik
s 
W
ee
kl
y/
 
W
ee
k
sl
ik
s 
D
ai
ly
 o
r 
A
lm
os
t D
ai
ly
/ 
D
a
a
g
lik
s 
of
 
a
m
p
er
 d
a
a
g
lik
s 
a. Tobacco products (cigarettes, chewing tobacco, cigars 
etc.) 
Tabak produkte (sigarette, kougom tabak, 
sigare ens) 
0 4 5 6 7 
b. Alcoholic beverages (beer, wine, spirits etc.) 
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 4 5 6 7 
c. Cannabis (marijuana, dagga, grass etc.) 
Cannabis (marijuana, dagga, ens) 
0 4 5 6 7 
d. Cocaine (coke, crack, etc.) 
Kokaine (coke, crack ens) 
 
0 4 5 6 7 
e. Amphetamine type stimulants (tik, speed, diet pills, 
ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet 
pille, ecstasy ens) 
0 4 5 6 7 
f. Inhalants (nitrous, glue, petrol, paint thinner etc) 
Inasemingsdwelm (nitrous, gom petrol, 
verfverdunner ens) 
 
0 4 5 6 7 
g. Sedatives or sleeping pills (Valium, Serepax, 
Rohypnol etc.) Kalmeermiddels of slaappille 
(Valium, Serepax, Rohypnol, etc.) 
 
0 4 5 6 7 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special 
K etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, 
Special K, etc.) 
 
0 4 5 6 7 
i. Opioids (heroin, morphine, methadone, codeine, etc.) 
Opioids ( Heroïen, morfien, methadone, codeine 
ens) 
 
0 4 5 6 7 
j. Other- specify 
Ander – spesifiseer- 
 
0 4 5 6 7 
k. Mandrax (Buttons, Whitepipe) 0 4 5 6 7 
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Question 5 
 
In the past three months, how often have you failed to do 
what was normally expected of you because of your use of 
(First drug, Second drug etc) 
 
In die afgelope drie maande, hoe dikwels het u versuim 
om te doen wat normaalweg van jou verwag word as 
gevolg van jou gebruik van (Eerste dwelm, tweede 
dwelm, ens) 
N
ev
er
/ N
oo
it
 
O
nc
e 
or
 T
w
ic
e/
 E
en
 o
f 
tw
ee
 k
ee
r 
M
on
th
ly
/ 
M
a
a
nd
el
ik
s 
W
ee
kl
y/
 
W
ee
k
sl
ik
s 
D
ai
ly
 o
r 
A
lm
os
t 
D
ai
ly
/ 
D
a
a
g
lik
s 
of
 
a
m
p
er
 d
a
a
g
lik
s 
a. Tobacco products (cigarettes, chewing tobacco, cigars 
etc.) 
Tabak produkte (sigarette, kougom tabak, 
sigare ens) 
0 5 6 7 8 
b. Alcoholic beverages (beer, wine, spirits etc.) 
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 5 6 7 8 
c. Cannabis (marijuana, dagga, grass etc.) 
Cannabis (marijuana, dagga, ens) 
 
0 5 6 7 8 
d. Cocaine (coke, crack etc.) 
Kokaine (coke, crack ens) 
 
0 5 6 7 8 
e. Amphetamine type stimulants (tik, speed, diet pills, 
ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet 
pille, ecstasy ens) 
 
0 5 6 7 8 
f. Inhalants (nitrous, glue, petrol, paint thinners etc.) 
Inasemingsdwelm (nitrous, gom petrol, 
verfverdunner ens) 
 
0 5 6 7 8 
g. Sedatives or sleeping pills (Valium, Serepax, 
Rohypnol etc.) 
Kalmeermiddels of slaappille (Valium, Serepax, 
Rohypnol, etc.) 
 
0 5 6 7 8 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special 
K etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, 
Special K, etc.) 
 
0 5 6 7 8 
i. Opioids (heroin, morphine, methadone, codeine etc.) 
Opioids ( Heroïen, morfien, methadone, codeine 
ens) 
0 5 6 7 8 
j. Other- specify 
Ander – spesifiseer- 
 
0 5 6 7 8 
k. Mandrax (Buttons, Whitepipe) 0 5 6 7 8 
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Question 6 
 
Has a friend or relative or anyone else ever expressed concern 
about your use of (First drug, Second drug etc) 
 
Het 'n vriend of familielid of enigiemand anders ooit  sy 
kommer uitgespreek oor jou gebruik van (Eerste dwelms, 
Tweede dwelms ens) 
 
N
ev
er
 
N
oo
it
 
Y
es
, i
n 
th
e 
pa
st
 3
 
m
on
th
s 
Y
es
, b
ut
 n
ot
 in
 th
e 
pa
st
 th
re
e 
m
on
th
s 
a. Tobacco products (cigarettes, chewing tobacco, cigars 
etc.) 
Tabak produkte (sigarette, kougom tabak, sigare 
ens) 
0 6 3 
b. Alcoholic beverages (beer, wine, spirits etc.) 
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 6 3 
c. Cannabis (marijuana, dagga, grass etc.) 
Cannabis (marijuana, dagga, ens) 
 
0 6 3 
d. Cocaine (coke, crack etc.) 
Kokaine (coke, crack ens) 
 
0 6 3 
e. Amphetamine type stimulants (tik, speed, diet pills, 
ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet pille, 
ecstasy ens) 
 
0 6 3 
f. Inhalants (nitrous, glue, petrol, paint thinners etc.) 
Inasemingsdwelm (nitrous, gom petrol, 
verfverdunner ens) 
 
0 6 3 
g. Sedatives or sleeping pills (Valium, Serepax, Rohypnol 
etc.) 
Kalmeermiddels of slaappille (Valium, Serepax, 
Rohypnol, etc.) 
 
0 6 3 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special K 
etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, Special 
K, etc.) 
 
0 6 3 
i. Opioids (heroin, morphine, methadone, codeine, etc.) 
Opioids ( Heroïen, morfien, methadone, codeine 
ens) 
 
0 6 3 
j. Other- specify 
Ander – spesifiseer- 
 
0 6 3 
k. Mandrax (Buttons, Whitepipe) 0 6 3 
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Question 7 
 
Have you ever tried and failed to control, cut down or stop 
using (First drug, Second drug etc.)?    
 
Het jy al ooit probeer en gefaal om die gebruik te beheer, 
te verminder of  te stop (Eerste dwelm, Tweede dwelm ens) 
 
N
ev
er
 
N
oo
it
 
Y
es
, i
n 
th
e 
pa
st
 3
 
m
on
th
s 
Y
es
, b
ut
 n
ot
 in
 
th
e 
pa
st
 th
re
e 
m
on
th
s 
a. Tobacco products (cigarettes, chewing tobacco, cigars 
etc) 
Tabak produkte (sigarette, kougom tabak, sigare 
ens) 
0 6 3 
b. Alcoholic beverages (beer, wine, spirits, etc.) 
Alkoholiese drank (bier, wyn, spiritualieë, ens) 
 
0 6 3 
c. Cannabis (marijuana, dagga, grass etc.) 
Cannabis (marijuana, dagga, ens) 
 
0 6 3 
d. Cocaine (coke, crack etc.) 
Kokaine (coke, crack ens) 
 
0 6 3 
e. Amphetamine type stimulants (tik, speed, diet pills, 
ecstasy etc.) 
Amfetamien tipe stimulante (tik, speed, dieet pille, 
ecstasy ens) 
 
0 6 3 
f. Inhalants (nitrous, glue, petrol, paint thinners etc.) 
Inasemingsdwelm (nitrous, gom petrol, 
verfverdunner ens) 
 
0 6 3 
g. Sedatives or sleeping pills (Valium, Serepax, Rohypnol 
etc) 
Kalmeermiddels of slaappille (Valium, Serepax, 
Rohypnol, etc.) 
 
0 6 3 
h. Hallucinogens (LSD, acid, mushrooms, PCP, Special K 
etc.) 
Hallusinogene(LSD, acid, mushrooms, PCP, Special 
K, etc.) 
 
0 6 3 
i. Opioids (heroin, morphine, methadone, codeine etc.) 
Opioids ( Heroïen, morfien, methadone, codeine 
ens) 
 
0 6 3 
j. Other- specify 
Ander – spesifiseer- 
 
0 6 3 
k. Mandrax (Buttons, Whitepipe) 0 6 3 
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SOCRATES: Personal Drug/Drink Use Questionnaire 
 
SOCRATES QUESTIONNAIRE 
For each statement circle one number from 1 to 5 to indicate how much you agree or disagree with it right 
now. Only circle one number for each statement. 
(Vir elke stelling, omkring een nommer tussen 1 en 5 om te wys hoeveel jy met die stelling saamstem of nie. 
Omkring slegs een nommer vir elke stelling)  
 
 NO! 
Strongly 
Disagree 
No 
Disagree 
? 
Undecided 
or unsure 
Yes 
Agree 
Yes! 
Strongly 
Agree 
1. I really want to make changes in 
my use of drugs/alcohol. 
Ek wil daadwerklike veranderinge 
maak in my drank/dwelm 
gewoontes. 
1 2 3 4 5 
2. Sometimes I wonder if I am an 
addict/alcoholic. 
Ek wonder soms of ek verslaaf is. 
1 2 3 4 5 
3. If I don’t change my drug/alcohol 
use soon, my problems are going 
to get worse. 
As ek nie my drank/dwelm 
gebruik verander nie, gaan my 
probleme erger word. 
1 2 3 4 5 
4. I have already started making 
some changes in my use of 
drugs/alcohol. 
Ek het al klaar veranderinge in 
my drank / dwelm gebruik begin 
maak. 
1 2 3 4 5 
5. I was using/drinking too much at 
one time, but I’ve managed to 
change that. 
Ek het op 'n stadium te veel 
gedrink/dwelms gebruik, maar ek 
het dit verander. 
1 2 3 4 5 
6. Sometimes I wonder if my 
drug/alcohol use is hurting other 
people. 
Ek wonder partykeer of my 
drank/dwelm gebruik ander 
mense seermaak. 
1 2 3 4 5 
7. I have a drug/alcohol problem. 
Ek het 'n drank/dwelm problem. 
1 2 3 4 5 
8. I’m not just thinking about 
changing my drug/alcohol use, I’m 
already doing something about it. 
Ek dink nie net daaraan om my 
drank/dwelm gebruik te verander 
nie, ek doen alreeds iets daaraan. 
1 2 3 4 5 
9. I have already changed my 
drug/alcohol use, and I am looking 
for ways to keep from slipping 
back to my old pattern. 
Ek het alreeads veranderinge aan 
1 2 3 4 5 
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my drank/dwelm gebruik gemaak 
en soek maniere om nie weer 
daartoe terug te keer nie. 
10. I have serious problems with 
drugs/alcohol. 
Ek het ernstige probleme met 
dwelms. 
1 2 3 4 5 
11. Sometimes I wonder if I am in 
control of my drug/alcohol use. 
Ek wonder partykeer of ek in 
beheer van my drank / dwelm 
gebruik is. 
1 2 3 4 5 
12. My drug/alcohol use is causing a 
lot of harm. 
My drank / dwelm gebruik 
veroorsaak baie problem. 
1 2 3 4 5 
13. I am actively doing things now to 
cut down or stop my use of 
drugs/alcohol. 
Ek is aktief besig om my 
drank/dwelm gebruik af te skaal 
of te stop. 
1 2 3 4 5 
14. I want help to keep from going 
back to the drug/alcohol problems 
that I had before. 
Ek benodig hulp om te keer dat ek 
terug gaan na drank/dwelm 
misbruik. 
1 2 3 4 5 
15. I know that I have a drug/alcohol 
problem. 
Ek weet ek het 'n drank/ dwelm 
problem. 
1 2 3 4 5 
16. There are times when I wonder if I 
use drugs/alcohol too much. 
Daar is tye wat ek wonder of ek te 
veel drink/ dwelms gebruik. 
1 2 3 4 5 
17. I am a drug addict/alcoholic. 
Ek is verslaaf aan drank/dwelms. 
1 2 3 4 5 
18. I am working hard to change my 
drug/alcohol use. 
Ek werk hard daaraan om 
veranderinge te maak aan my 
drank/dwelm gebruik. 
1 2 3 4 5 
19. I have made some changes in my 
drug/alcohol use, and I want some 
help to keep from going back to 
the way I used/drank before. 
Ek het al veranderinge gemaak 
aan my drank/dwelm gebruik en 
ek benodig hulp om te keer dat ek 
terug gaan na my misbruik 
daarvan. 
1 2 3 4 5 
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DTCQ-8:  Self-Efficacy Questionnaire 
 
SELF-EFFICACY QUESTIONNAIRE 
I would resist the urge to drink heavily/use if: 
Ek sal die behoefte weerhou om te veel te drink of dwelms te gebruik as: 
                                                                                        Response scale: 0 = not at all confident 
                                                                                                                100 = very confident 
1.  . . I were angry at the way things had turned out.                    0…..20…..40…..60…..80…..100 
 
                  Ek was kwaad oor hoe dinge uitgedraai het. 
2.   . . I had trouble sleeping.                                                        0…..20…..40…..60…..80…..100 
 
      Ek sukkel om te slap. 
3.  . .  I remembered something that had happened.                     0…..20…..40…..60…..80…..100 
 
      Ek het iets onthou wat gebeur het. 
4.  . . I wanted to find out whether I could drink/use                      0…..20…..40…..60…..80…..100 
                 occasionally without getting hooked. 
 
                  Ek wou uitvind of ek nou en dan kon drink of dwelms 
                  gebruik sonder om verslaaf te raak. 
5.  . . I unexpectedly found some alcohol/drugs or                        0…..20…..40…..60…..80…..100  
                 happened to see something that reminded me 
                 of drinking/drugging. 
 
                  Ek het onverwags drank/dwelms gevind of iets gesien  
                  wat my herineer het aan drink en dwelm misbruik. 
6.   . .Other people treated me unfairly or interfered                     0…..20…..40…..60…..80…..100 
                  with my plans. 
 
                   Ander mense het my onregverdig behandel of  
                   ingemeng met my planne. 
7. .. . I were out with friends and they kept suggesting we go   0…..20…..40…..60…..80…..100 
     somewhere and drink/use. 
 
    As ek saam met my vriende was en hulle stel voor dat ons 
     moet drink en dwelm misbruik. 
8. .. I wanted to celebrate with a friend.                                  0…..20…..40…..60…..80…..100 
 
                Ek wil met a vriend gaan vier . 
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Appendix E 
Treatment Services Assessment 
 
 Disagree Somewhat 
Agree 
 
Agree Strongly 
Agree 
Does 
not 
Apply 
1.The amount of time I had to wait to get  
    services was acceptable to me. 
 
1 2 3 4 0 
 
2. The staff treated me with respect. 
 
1 2 3 4 0 
3. The staff at this treatment Centre are 
sensitive to my background. 
 
1 2 3 4 0 
4. The people I went to for treatment 
services spent enough time with me. 
 
1 2 3 4 0 
5. I have access to all the services I need 
in this treatment Centre for my 
recovery. 
 
1 2 3 4 0 
6. This treatment Centre helps me reduce 
my HIV risk. 
 
1 2 3 4 0 
7. I would recommend this service to 
others. 
1 2 3 4 0 
 
 
8. How in your opinion could this 
programme be improved? 
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Consent Form 
 
Consent to participate in a research study 
Toestemming om aan 'n navorsings studie deel te neem 
Dear Client, Beste Klient 
Formal Title: Formele Titel: 
Outcomes based evaluative research at a Cape Town substance abuse treatment centre 
Uitkoms gebasseerde evaluerings studie by 'n Kaapstadse dwelm sentrum 
 
Study Purpose Doel van Studie 
You are being invited to participate in a research study being conducted by researchers from 
the University of Cape Town. The purpose of the study is to assist the particular treatment 
centre as well as its present and future community, by addressing problematic issues related 
to relapse and the premature termination of treatment, in addition to identifying those 
components of the treatment programme associated with its success. 
U word genooi om deel te neem aan 'n studie wat uitgevoer word deur navorsers van die 
Universiteit van Kaapstad. Die doel van die studie is om die spesifieke sentrum asook hul 
huidige en toekomstige gemeenskap by te staan deur die problematiese kwessies aan te 
spreek wat verband hou met terugval van drank/ en –dwelm gebruikders asook 
vroegtydige terminasie van behandeling, en ook om die komponente van die  behandelings 
program wat met die sukses daarvan te doen het, te identifiseer. 
 
Study Procedures Studie Prosedures 
If you decide to participate in this study, you will be asked to complete a set of 
questionnaires on admission to ascertain your previous levels of substance use and your 
perceptions of your own substance use. The entire process should take no longer than 20 
minutes. Similar questionnaires will be administered on completion of the programme and 
again one month after completion of treatment and possibly at longer intervals thereafter. 
The follow- up questions may either be asked telephonically or administered as paper or 
pencil questionnaires at after care.  
As u besluit om deel te neem aan hierdie studie, sal u gevra word om 'n stel vraelyste met u 
toelating te voltooi om vas te stel wat u vorige vlakke van drank/dwlem gebruik was asook 
om vas te stel wat u eie persepsie van u drank/dwelm gebruik is. Die hele proses behoort nie 
langer as 20 minute te duur nie. Dieselfde soort vraelyste sal uitgedeel word aan die einde 
van die program en weer na 'n maand aan die einde van die behandeling, en dalk ook in 
langer periods daarna. Die opvolg vrae sal dan óf telefonies óf op papier beantwoord word, 
of in potlood by die nasorg sessies. 
 
Possible Risks Moontlike Risikos 
There are no foreseen psychological risks. 
Daar is geen voorsiene sielkundieg risikos nie. 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
112 
 
Appendix F 
 
Possible Benefits Moontlike voordele 
There are no direct benefits to you in participating in this study but by agreeing to participate 
you are helping us understand effective substance abuse treatments better. 
(Daar is geen direkte voordele vir u as u in hierdie studie deel neem nie, maar deur toe te 
stem om deel te neem help u vir ons om drank/dwelm misbruik beter te verstaan.) 
 
Confidentiality Konfidensialiteit 
The researcher will be the only person aware of your identity and you are assured that she 
will keep this confidential. Centre staff will have no access at any stage to any of the 
completed questionnaires. You are assured of complete confidentiality, with identifying 
information on this consent form and data collection forms being kept in separate locked 
cabinets and unavailable to anyone other than the researchers and certain university officials 
who may audit project files. Any reports about the study will not identify you or any other 
study participant. Your telephone numbers will also be kept at all times in a locked cabinet. 
Die navorser is die enigste persoon wat sal weet wie u is en u kan verseker wees dat sy dit 
konfidentieel sal hou. Die personeel by die sentrum het geen toegang tot enige van die 
voltooide vraelyste nie. U kan verseker wees dat dit streng konfidentieel gehou sal word, en 
dat die inligting op hierdie toestemmingsvorm en die data –insamelingsvorms toegesluit 
word in kabinette en dat dit nie beskikbaar is aan enige iemand behalwe die navorsers en 
seker universiteits amptenare wat die projek leêrs dalk mag oudit nie. Enige verslae van die 
studie sal nie u of enige ander deelnemers se identiteit ontbloot nie.  
 
Voluntary Participation Vrywillge Deelname 
Participation in this study is entirely voluntary. You may refuse to answer any question and 
you may withdraw from the study at any point in time. If you choose not to participate in this 
study it will not affect your relationship with the treatment centre in any way. 
Deelname in hierdie studie is totaal vrywillig. U mag weier om enige van die vrae te 
beantwoord en u mag op enige stadium onttrek van die studie. As u kies om nie deel te 
neem aan hierdie studie nie, sal dit op geen manier die verhouding wat u met hierdie 
sentrum het, benadeel nie. 
 
Debriefing Ontlonting 
On completion of the writing up of the final research report a copy will be sent to the 
treatment centre and may be viewed there after February 2012. 
Aan die einde van die finale navorsings verslag sal 'n afskrif van die verslag na die 
behandeling sentrum gestuur word en dit kan gesien word na Februarie 2012. 
  
Questions Vrae 
Any questions related to this study may be addressed to: 
Enige vrae in verband met hierdie studie kan geadresseer word aan: 
 
Lynda Duffett  0824343490 
Dr Catherine Ward 021 6503422 
Department of Psychology, UCT   021 6503417 
Departement van Sielkunde, UK 
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____________________________   _____________________________ 
Signature of participant    Date (Datum) 
(Handtekening van deelnemer) 
 
 
 
______________________________   _________________________ 
Name of participant (printed)    Witness (Getuie) 
(Naam van deelnemer (drukskrif) ) 
 
 
    
______________________________ 
Participant’s home telephone number 
(Deelnemer se huis telefoon nommer) 
 
 
 
_____________________________ 
Participant’s cellphone number   
(Deelnemer se selfoon nommer) 
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Appendix G 
Sessions Attended by Type 
 
Table G1 
 
Individual sessions attended for those in treatment 
     Dosage as % 
(18) Freq. Percentage 
Cumulative 
Percentage 
 0% 27 19% 19% 
 
17% 25 18% 37% 
 
33% 16 11% 48% 
 
50% 22 15% 63% 
 
67% 11 8% 71% 
 
83% 18 13% 84% 
 
100% 12 8% 92% 
 
117% 3 2% 94% 
 
133% 4 3% 97% 
 
150% 4 3% 100% 
 
Total 142 100% 
 
 
 
 
 
Table G2 
 
Lecture sessions attended for those in treatment 
    Dosage as % 
(18) Freq. Percentage 
Cumulative 
Percentage 
 
0% 
 
11 
 
8% 
 
8% 
17% 40 28% 0% 
33% 24 17% 0% 
50% 8 6% 0% 
67% 14 10% 0% 
83% 15 11% 0% 
100% 20 14% 0% 
117% 6 4% 0% 
133% 3 2% 0% 
167% 1 1% 0% 
Total 142 100% 
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Table G3 
 
Group sessions attended for those in treatment 
    Dosage as % 
(18) Freq. Percentage 
Cumulative 
Percentage 
0% 29 20% 20% 
17% 22 15% 36% 
33% 20 14% 50% 
50% 14 10% 60% 
67% 19 13% 73% 
83% 17 12% 85% 
100% 13 9% 94% 
117% 4 3% 97% 
133% 3 2% 99% 
167% 1 1% 100% 
Total 142 100% 
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Regression Results for Imputed Data Analyses (n=142) 
 
Table H1 
       
 
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and Dosage 
Parameter Estimate Std. Error df    t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 64.93 3.79 225.26 17.15 .000 57.47 72.39 
Time -29.07 3.75 277.09 -7.75 .000 -36.45 -21.69 
Dosage -16.25 5.14 277.03 -3.16 .002 -26.36 -6.13 
 
Table H2 
 
       
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and Previous Clean Time 
 
Parameter Estimate Std. Error df    t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 57.44 4.09 201.96 14.04 .000 49.37 65.51 
Time -29.50 4.11 253.52 -7.18 .000 -37.58 -21.41 
Previous Clean Time 0.27 0.93 253.50 0.29 .768 -1.55 2.10 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
 
117 
Appendix H 
Table H3 
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and AA Affiliation 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 55.07 2.96 162.00 18.59 .000 49.22 60.92 
Time -29.48 3.80 280.00 -7.77 .000 -36.95 -22.01 
AA Affiliation 1.62 0.96 271.63 1.68 .093 -0.27 3.51 
 
Table H4 
 
       
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and Self-Efficacy 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 76.95 4.31 275.24 17.87 .000 68.47 85.43 
Time -22.61 3.76 276.84 -6.01 .000 -30.02 -15.21 
Self-Efficacy -0.06 0.01 232.65 -6.08 .000 -0.08 -0.04 
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Table H5 
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and SOCRATES Taking Steps 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 110.79 14.33 270.72 7.73 .000 82.57 139.01 
Time -27.65 3.77 262.56 -7.33 .000 -35.07 -20.23 
SOCRATES Taking Steps -1.55 0.40 269.46 -3.89 .000 -2.33 -0.76 
Appendix H 
Table H6 
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and SOCRATES Recognition 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 24.02 11.96 252.54 2.01 .046 .47 47.57 
Time -28.73 3.78 267.71 -7.61 .000 -36.17 -21.30 
SOCRATES Recognition 1.01 .36 242.25 2.77 .006 .29 1.72 
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Appendix H 
Table H7 
Regression Results for Imputed Data Analyses (n=142): Global ASSIST vs. Time and SOCRATES Ambivalence 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 92.65 5.03 247.76 18.42 .000 82.74 102.55 
Time -40.24 3.70 257.94 -10.88 .000 -47.52 -32.96 
SOCRATES Ambivalence -0.44 0.05 142.46 -8.85 .000 -0.54 -0.34 
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Appendix I 
 Regression Results for Non-Imputed Data Analyses (n=98) 
 
Table I1 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and Dosage 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 61.35 4.17 147.96 14.71 .000 53.10 69.59 
Time -42.12 3.98 146.00 -10.57 .000 -50.00 -34.25 
Dosage -9.52 4.21 145.26 -2.26 .025 -17.85 -1.19 
 
Table I2 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and Dosage 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 57.75 4.49 128.34 12.85 .000 48.86 66.65 
Time -43.24 4.35 130.61 -9.94 .000 -51.85 -34.63 
Previous Clean Time -0.12 0.77 129.87 -0.15 .878 -1.64 1.40 
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Appendix I 
Table I3 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and AA Affiliation 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 56.40 3.64 105.94 15.50 .000 49.19 63.62 
Time -42.10 4.01 148.38 -10.49 .000 -50.03 -34.17 
AA -0.07 0.79 134.05 -0.08 .934 -1.62 1.49 
 
Table I4 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and Self-Efficacy 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 66.08 4.47 176.28 14.77 .000 57.25 74.91 
Time -37.62 4.13 161.82 -9.11 .000 -45.78 -29.47 
Self-Efficacy -0.03 0.01 124.60 -3.47 .001 -0.04 -0.01 
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Appendix I 
Table I5 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and SOCRATES Taking Steps 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 89.87 15.12 175.41 5.94 .000 60.03 119.72 
Time -40.29 4.09 150.20 -9.85 .000 -48.38 -32.21 
SOCRATES Taking Steps -0.94 0.41 167.65 -2.27 .025 -1.75 -0.12 
 
Table I6 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and SOCRATES Recognition 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 38.25 9.74 152.96 3.92 .000 19.00 57.50 
Time -41.29 4.01 149.66 -10.31 .000 -49.20 -33.37 
SOCRATES Recognition 0.57 0.28 125.75 2.01 .046 0.01 1.13 
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Appendix I 
 
Table I7 
Regression Results for Non-Imputed Data Analyses (n=98): Global ASSIST vs. Time and SOCRATES Ambivalence 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 52.79 12.43 148.34 4.25 .000 28.21 77.36 
Time -42.23 4.03 147.17 -10.47 .000 -50.20 -34.26 
SOCRATES Ambivalence 0.05 0.14 131.54 0.32 .752 -0.24 0.33 
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Appendix J 
Substance Use Tables 
 
 
Table J1 
         
          Substance use at admission for individuals using Alcohol (Once/Twice) only at 10 weeks post-admission 
          Participant Number Alcohol Cannabis Cocaine Methamphetamine Sedatives Hallucinogens Opioids Other Mandrax 
13 Daily 
 
Once/Twice 
     16 Weekly 
  
Daily 
     19 Weekly 
        20 Once/Twice 
 
Daily 
     34 Weekly Weekly 
   
Once/Twice 
  38 Once/Twice 
 
Weekly Once/Twice 
   45 Monthly 
  
Weekly 
     50 Daily Daily 
 
Weekly 
     53 Once/Twice 
 
Monthly 
     75 Weekly Daily Once/Twice Daily 
  
Daily 
 
Daily 
76 Weekly Daily 
   
Once/Twice 
  84 Weekly Weekly 
       90 Weekly     Weekly           
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Appendix J 
 
Table  J2 
     
      Substance use at admission for individuals using Alcohol (Weekly) only at 10 weeks post-
admission 
      Participant 
Number 
Alcohol Cannabis Cocaine Methamphetamine Hallucinogens 
32 Daily 
    55 Monthly Once/Twice Monthly 
 64 Weekly Weekly 
   82 Daily Daily Once/Twice Once/Twice 
87 Weekly 
  
Weekly 
 88 Weekly Weekly   Once/Twice Once/Twice 
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Appendix K 
Regression Results for Non-Imputed Data Analyses (n=89) 
 
 
Table K1 
 
Regression Results for Non-Imputed Data Analyses (n=89): Comparing Admission to 6 Weeks Post-
Admission  and 10 Weeks Post-Admission: Global ASSIST vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence 
Interval 
Lower Bound 
Upper 
Bound 
Intercept (Admission) 55.10 3.58 88.00 15.40 0.00 47.99 62.21 
6 Weeks Post-Admission -39.21 4.03 132.15 -9.73 0.00 -47.19 -31.24 
10 Weeks Post-Admission -42.12 3.96 125.62 -10.64 0.00 -49.96 -34.29 
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Appendix K 
Table K2 
Regression Results for Non-Imputed Data Analyses (n=89): Comparing 6 Weeks Post-Admission to Admission and  
10 Weeks Post-Admission: Global ASSIST vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept (6 Weeks Post-
Admission) 
15.89 1.86 88.00 8.56 .000 12.20 19.58 
10 Weeks Post-Admission -2.91 2.51 174.58 -1.16 .249 -7.87 2.05 
Admission 39.21 4.03 132.15 9.73 .000 31.24 47.19 
        
 
 
       
Table K3 
Regression Results for Non-Imputed Data Analyses (n=89): Comparing Admission to 6 Weeks Post-
Admission and 10 Weeks Post-Admission : Substance Use  vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence 
Interval 
Lower Bound 
Upper 
Bound 
Intercept (Admission) 12.28 0.74 88.00 16.49 0.00 10.80 13.76 
6 Weeks Post-Admission -9.06 0.86 140.32 -10.55 0.00 -10.75 -7.36 
10 Weeks Post-Admission -8.91 0.87 144.34 -10.25 0.00 -10.63 -7.19 
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Appendix K 
Table K4 
Regression Results for Non-Imputed Data Analyses (n=89): Comparing 6 Weeks Post-Admission to 
Admission and 10 Weeks Post-Admission: Substance Use  vs. Time 
 
Parameter Estimate Std. Error df t p 
95% Confidence 
Interval 
Lower Bound 
Upper 
Bound 
Intercept (6 Weeks Post 
Admission) 
3.37 0.45 88.00 7.52 0.00 2.48 4.26 
10 Weeks Post-Admission -0.15 0.62 175.61 -0.24 0.81 -1.37 1.08 
Admission 8.91 0.87 144.34 10.25 0.00 7.19 10.63 
 
Table K5 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and Dosage 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 22.53 2.32 144.16 9.71 .000 17.94 27.11 
6 Weeks Post-Admission -2.91 2.38 173.33 -1.22 .223 -7.61 1.79 
10 Weeks Post-Admission 39.21 4.03 126.81 9.74 .000 31.24 47.18 
Dosage -12.83 2.92 207.85 -4.39 .000 -18.59 -7.07 
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           Appendix K 
Table K6 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and Previous Clean Time 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 15.36 2.63 128.62 5.83 .000 10.15 20.56 
6 Weeks Post-Admission -3.27 2.71 154.13 -1.21 .229 -8.63 2.08 
10 Weeks Post-Admission 40.20 4.38 118.37 9.18 .000 31.53 48.87 
Previous Clean Time 0.22 0.53 188.12 0.42 .678 -0.83 1.28 
 
Table K7 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and NA/AA Affiliation 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 16.46 1.94 94.70 8.47 .000 12.60 20.31 
6 Weeks Post-Admission -2.82 2.51 172.87 -1.12 .263 -7.77 2.13 
10 Weeks Post-Admission 39.14 4.05 130.45 9.66 .000 31.13 47.16 
AA Affiliation -0.44 0.47 186.99 -0.94 .346 -1.37 0.48 
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Appendix K 
Table  K8 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and Self-Efficacy 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 29.32 3.66 190.75 8.02 .000 22.11 36.54 
6 Weeks Post-Admission -1.92 2.43 174.50 -0.79 .430 -6.71 2.87 
10 Weeks Post-Admission 35.82 4.04 138.76 8.88 .000 27.84 43.80 
Self-Efficacy -0.03 0.01 150.65 -4.21 .000 -0.04 -0.01 
 
Table K9 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and SOCRATES Taking Steps 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 54.16 11.75 233.50 4.61 .000 31.02 77.31 
6 Weeks Post-Admission -2.53 2.46 171.84 -1.03 .305 -7.40 2.33 
10 Weeks Post-Admission 37.35 4.10 133.56 9.12 .000 29.25 45.45 
SOCRATES Taking Steps -1.02 0.31 234.50 -3.32 .001 -1.63 -0.41 
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Appendix K 
Table K10 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and SOCRATES Recognition 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 1.95 5.60 177.90 0.35 .728 -9.11 13.01 
6 Weeks Post-Admission -2.20 2.51 170.89 -0.88 .383 -7.16 2.76 
10 Weeks Post-Admission 39.34 4.02 131.18 9.78 .000 31.38 47.29 
SOCRATES Recognition 0.44 0.17 186.74 2.60 .010 0.11 0.77 
 
Table K11 
 
Regression Results for Non-Imputed Data Analyses (n=89): Global ASSIST vs. Time and SOCRATES Ambivalence 
Parameter Estimate Std. Error df t p 
95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 11.03 8.30 197.57 1.33 .186 -5.35 27.41 
6 Weeks Post-Admission -2.52 2.54 171.76 -0.99 .322 -7.52 2.49 
10 Weeks Post-Admission 39.74 4.07 130.77 9.76 .000 31.69 47.79 
SOCRATES Ambivalence 0.05 0.10 199.42 0.58 .566 -0.13 0.24 
 
